Frequencies for first 10,000 rows of pt variable in reac2010q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 14 0.14 0.14 ABDOMINAL ABSCESS | 3 0.03 0.17 ABDOMINAL ADHESIONS | 2 0.02 0.19 ABDOMINAL DISCOMFORT | 18 0.18 0.37 ABDOMINAL DISTENSION | 19 0.19 0.56 ABDOMINAL HERNIA | 4 0.04 0.60 ABDOMINAL PAIN | 44 0.44 1.04 ABDOMINAL PAIN LOWER | 4 0.04 1.08 ABDOMINAL PAIN UPPER | 33 0.33 1.41 ABDOMINAL REBOUND TENDERNESS | 1 0.01 1.42 ABDOMINAL SEPSIS | 1 0.01 1.43 ABNORMAL BEHAVIOUR | 10 0.10 1.53 ABNORMAL DREAMS | 5 0.05 1.58 ABNORMAL FAECES | 1 0.01 1.59 ABNORMAL SLEEP-RELATED EVENT | 1 0.01 1.60 ABORTION | 1 0.01 1.61 ABORTION INCOMPLETE | 8 0.08 1.69 ABORTION INDUCED | 5 0.05 1.74 ABORTION MISSED | 1 0.01 1.75 ABORTION SPONTANEOUS | 6 0.06 1.81 ABSCESS | 4 0.04 1.85 ABSCESS DRAINAGE | 2 0.02 1.87 ABSCESS JAW | 2 0.02 1.89 ABSCESS LIMB | 1 0.01 1.90 ABSCESS ORAL | 3 0.03 1.93 ACCELERATED HYPERTENSION | 1 0.01 1.94 ACCIDENT | 3 0.03 1.97 ACCIDENTAL DEATH | 1 0.01 1.98 ACCIDENTAL DRUG INTAKE BY CHILD | 6 0.06 2.04 ACCIDENTAL OVERDOSE | 19 0.19 2.23 ACID FAST BACILLI INFECTION | 1 0.01 2.24 ACIDOSIS | 4 0.04 2.28 ACNE | 3 0.03 2.31 ACQUIRED OESOPHAGEAL WEB | 1 0.01 2.32 ACTINIC KERATOSIS | 1 0.01 2.33 ACTINOMYCOSIS | 5 0.05 2.38 ACTINOMYCOTIC SKIN INFECTION | 1 0.01 2.39 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 4 0.04 2.43 ACTIVITIES OF DAILY LIVING IMPAIRED | 2 0.02 2.45 ACUTE ABDOMEN | 1 0.01 2.46 ACUTE CORONARY SYNDROME | 1 0.01 2.47 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 2.48 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 2 0.02 2.50 ACUTE HAEMORRHAGIC CONJUNCTIVITIS | 1 0.01 2.51 ACUTE HEPATIC FAILURE | 4 0.04 2.55 ACUTE LYMPHOCYTIC LEUKAEMIA | 1 0.01 2.56 ACUTE MYELOID LEUKAEMIA | 3 0.03 2.59 ACUTE MYELOID LEUKAEMIA RECURRENT | 1 0.01 2.60 ACUTE MYOCARDIAL INFARCTION | 5 0.05 2.65 ACUTE PRERENAL FAILURE | 2 0.02 2.67 ACUTE PULMONARY OEDEMA | 2 0.02 2.69 ACUTE RESPIRATORY DISTRESS SYNDROME | 7 0.07 2.76 ADENOMA BENIGN | 1 0.01 2.77 ADENOVIRUS INFECTION | 1 0.01 2.78 ADHESION | 2 0.02 2.80 ADRENAL CARCINOMA | 1 0.01 2.81 ADRENAL DISORDER | 1 0.01 2.82 ADRENAL INSUFFICIENCY | 4 0.04 2.86 ADRENAL SUPPRESSION | 1 0.01 2.87 ADRENOCORTICAL INSUFFICIENCY ACUTE | 2 0.02 2.89 ADVERSE DRUG REACTION | 9 0.09 2.98 ADVERSE EVENT | 6 0.06 3.04 AGEUSIA | 4 0.04 3.08 AGGRESSION | 12 0.12 3.20 AGITATION | 8 0.08 3.28 AGRANULOCYTOSIS | 1 0.01 3.29 ALANINE AMINOTRANSFERASE ABNORMAL | 1 0.01 3.30 ALANINE AMINOTRANSFERASE DECREASED | 1 0.01 3.31 ALANINE AMINOTRANSFERASE INCREASED | 15 0.15 3.46 ALBUMIN GLOBULIN RATIO DECREASED | 1 0.01 3.47 ALCOHOL ABUSE | 1 0.01 3.48 ALCOHOL INTERACTION | 1 0.01 3.49 ALCOHOL POISONING | 1 0.01 3.50 ALCOHOL USE | 1 0.01 3.51 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 3.52 ALLERGY TO CHEMICALS | 1 0.01 3.53 ALLERGY TO METALS | 1 0.01 3.54 ALOPECIA | 11 0.11 3.65 ALOPECIA AREATA | 1 0.01 3.66 ALPHA 1 GLOBULIN INCREASED | 1 0.01 3.67 ALPHA 2 GLOBULIN INCREASED | 1 0.01 3.68 ALTERED STATE OF CONSCIOUSNESS | 2 0.02 3.70 ALVEOLITIS ALLERGIC | 1 0.01 3.71 ALVEOLOPLASTY | 2 0.02 3.73 AMENORRHOEA | 4 0.04 3.77 AMMONIA ABNORMAL | 1 0.01 3.78 AMMONIA INCREASED | 1 0.01 3.79 AMNESIA | 23 0.23 4.02 AMPUTATION | 1 0.01 4.03 AMYLOIDOSIS | 2 0.02 4.05 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.06 ANAEMIA | 42 0.42 4.48 ANAEMIA MACROCYTIC | 1 0.01 4.49 ANAESTHESIA | 1 0.01 4.50 ANAESTHETIC COMPLICATION | 1 0.01 4.51 ANAL FISTULA | 2 0.02 4.53 ANALGESIC DRUG LEVEL DECREASED | 1 0.01 4.54 ANAPHYLACTIC REACTION | 9 0.09 4.63 ANAPHYLACTIC SHOCK | 7 0.07 4.70 ANEURYSM RUPTURED | 1 0.01 4.71 ANGER | 5 0.05 4.76 ANGINA PECTORIS | 10 0.10 4.86 ANGINA UNSTABLE | 1 0.01 4.87 ANGIODYSPLASIA | 2 0.02 4.89 ANGIOEDEMA | 6 0.06 4.95 ANGIOPATHY | 3 0.03 4.98 ANGIOPLASTY | 3 0.03 5.01 ANHEDONIA | 3 0.03 5.04 ANIMAL BITE | 1 0.01 5.05 ANISOCYTOSIS | 1 0.01 5.06 ANKLE FRACTURE | 6 0.06 5.12 ANKYLOSING SPONDYLITIS | 1 0.01 5.13 ANORECTAL DISORDER | 1 0.01 5.14 ANORECTAL ULCER | 1 0.01 5.15 ANOSMIA | 3 0.03 5.18 ANOXIC ENCEPHALOPATHY | 1 0.01 5.19 ANTI-INSULIN ANTIBODY | 1 0.01 5.20 ANTIBODY TEST ABNORMAL | 1 0.01 5.21 ANTICONVULSANT DRUG LEVEL DECREASED | 1 0.01 5.22 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 5.23 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 5.24 ANTIPHOSPHOLIPID SYNDROME | 2 0.02 5.26 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAP.. | 1 0.01 5.27 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 5.28 ANURIA | 8 0.08 5.36 ANXIETY | 51 0.51 5.87 AORTIC ARTERIOSCLEROSIS | 1 0.01 5.88 AORTIC CALCIFICATION | 2 0.02 5.90 AORTIC VALVE DISEASE | 1 0.01 5.91 AORTIC VALVE INCOMPETENCE | 1 0.01 5.92 AORTIC VALVE REPLACEMENT | 1 0.01 5.93 APATHY | 2 0.02 5.95 APHAGIA | 2 0.02 5.97 APHASIA | 10 0.10 6.07 APHONIA | 1 0.01 6.08 APHTHOUS STOMATITIS | 1 0.01 6.09 APLASIA PURE RED CELL | 1 0.01 6.10 APLASTIC ANAEMIA | 1 0.01 6.11 APPENDICEAL ABSCESS | 1 0.01 6.12 APPENDICECTOMY | 1 0.01 6.13 APPENDICITIS | 3 0.03 6.16 APPENDICITIS PERFORATED | 1 0.01 6.17 APPENDIX DISORDER | 1 0.01 6.18 APPLICATION SITE BLEEDING | 1 0.01 6.19 APPLICATION SITE BURN | 1 0.01 6.20 APPLICATION SITE IRRITATION | 1 0.01 6.21 APPLICATION SITE PRURITUS | 2 0.02 6.23 APPLICATION SITE RASH | 2 0.02 6.25 APPLICATION SITE REACTION | 3 0.03 6.28 APPLICATION SITE VESICLES | 1 0.01 6.29 ARRHYTHMIA | 11 0.11 6.40 ARTERIAL DISORDER | 1 0.01 6.41 ARTERIAL OCCLUSIVE DISEASE | 3 0.03 6.44 ARTERIAL RESTENOSIS | 1 0.01 6.45 ARTERIAL STENOSIS | 1 0.01 6.46 ARTERIOSCLEROSIS | 6 0.06 6.52 ARTHRALGIA | 49 0.49 7.01 ARTHRITIS | 11 0.11 7.12 ARTHRITIS INFECTIVE | 1 0.01 7.13 ARTHROPATHY | 8 0.08 7.21 ARTIFICIAL CROWN PROCEDURE | 1 0.01 7.22 ASCITES | 11 0.11 7.33 ASPARTATE AMINOTRANSFERASE INCREASED | 16 0.16 7.49 ASPERGILLOSIS | 3 0.03 7.52 ASPHYXIA | 1 0.01 7.53 ASPIRATION PLEURAL CAVITY | 1 0.01 7.54 ASTHENIA | 77 0.77 8.31 ASTHMA | 16 0.16 8.47 ATAXIA | 5 0.05 8.52 ATELECTASIS | 6 0.06 8.58 ATRIAL FIBRILLATION | 20 0.20 8.78 ATRIAL FLUTTER | 4 0.04 8.82 ATRIAL SEPTAL DEFECT ACQUIRED | 1 0.01 8.83 ATRIOVENTRICULAR BLOCK | 3 0.03 8.86 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 8.89 AURICULAR SWELLING | 1 0.01 8.90 AUTOIMMUNE DISORDER | 1 0.01 8.91 AUTOIMMUNE HEPATITIS | 1 0.01 8.92 AUTOIMMUNE THROMBOCYTOPENIA | 2 0.02 8.94 AXILLARY MASS | 3 0.03 8.97 AXILLARY VEIN THROMBOSIS | 1 0.01 8.98 AZOTAEMIA | 1 0.01 8.99 B-CELL LYMPHOMA | 1 0.01 9.00 BACK DISORDER | 7 0.07 9.07 BACK INJURY | 1 0.01 9.08 BACK PAIN | 43 0.43 9.51 BACTERAEMIA | 4 0.04 9.55 BACTERIAL TEST POSITIVE | 1 0.01 9.56 BALANCE DISORDER | 29 0.29 9.85 BARRETT'S OESOPHAGUS | 2 0.02 9.87 BASAL CELL CARCINOMA | 8 0.08 9.95 BASE EXCESS DECREASED | 1 0.01 9.96 BASEDOW'S DISEASE | 2 0.02 9.98 BEDRIDDEN | 4 0.04 10.02 BEHCET'S SYNDROME | 2 0.02 10.04 BENIGN COLONIC NEOPLASM | 1 0.01 10.05 BENIGN NEOPLASM OF THYROID GLAND | 1 0.01 10.06 BENIGN PROSTATIC HYPERPLASIA | 1 0.01 10.07 BILE DUCT CANCER | 1 0.01 10.08 BILE DUCT OBSTRUCTION | 2 0.02 10.10 BILE DUCT STENOSIS | 2 0.02 10.12 BILIARY CIRRHOSIS PRIMARY | 1 0.01 10.13 BILIARY COLIC | 1 0.01 10.14 BILIARY DILATATION | 2 0.02 10.16 BILIARY TRACT DISORDER | 2 0.02 10.18 BILIRUBIN CONJUGATED INCREASED | 1 0.01 10.19 BIOPSY BONE MARROW ABNORMAL | 1 0.01 10.20 BIOPSY MUSCLE ABNORMAL | 1 0.01 10.21 BIOPSY STOMACH | 1 0.01 10.22 BIOPSY UTERUS | 1 0.01 10.23 BIPOLAR DISORDER | 4 0.04 10.27 BIPOLAR II DISORDER | 1 0.01 10.28 BK VIRUS INFECTION | 1 0.01 10.29 BLADDER CANCER | 3 0.03 10.32 BLADDER CANCER RECURRENT | 1 0.01 10.33 BLADDER CATHETERISATION | 1 0.01 10.34 BLADDER DISORDER | 2 0.02 10.36 BLADDER MASS | 1 0.01 10.37 BLADDER NECROSIS | 1 0.01 10.38 BLADDER NEOPLASM | 1 0.01 10.39 BLADDER NEOPLASM SURGERY | 1 0.01 10.40 BLADDER OBSTRUCTION | 1 0.01 10.41 BLADDER OPERATION | 1 0.01 10.42 BLADDER PROLAPSE | 2 0.02 10.44 BLADDER SPASM | 1 0.01 10.45 BLADDER TRANSITIONAL CELL CARCINOMA S.. | 1 0.01 10.46 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 10.47 BLINDNESS | 7 0.07 10.54 BLINDNESS TRANSIENT | 1 0.01 10.55 BLINDNESS UNILATERAL | 4 0.04 10.59 BLISTER | 14 0.14 10.73 BLOOD ALBUMIN DECREASED | 2 0.02 10.75 BLOOD ALBUMIN INCREASED | 1 0.01 10.76 BLOOD ALKALINE PHOSPHATASE INCREASED | 11 0.11 10.87 BLOOD AMYLASE INCREASED | 4 0.04 10.91 BLOOD BETA-D-GLUCAN INCREASED | 1 0.01 10.92 BLOOD BICARBONATE DECREASED | 2 0.02 10.94 BLOOD BILIRUBIN INCREASED | 12 0.12 11.06 BLOOD BLISTER | 1 0.01 11.07 BLOOD CALCIUM DECREASED | 1 0.01 11.08 BLOOD CALCIUM INCREASED | 1 0.01 11.09 BLOOD CHOLESTEROL INCREASED | 8 0.08 11.17 BLOOD CORTICOTROPHIN DECREASED | 1 0.01 11.18 BLOOD CORTISOL ABNORMAL | 1 0.01 11.19 BLOOD CORTISOL DECREASED | 1 0.01 11.20 BLOOD COUNT ABNORMAL | 3 0.03 11.23 BLOOD CREATINE PHOSPHOKINASE | 1 0.01 11.24 BLOOD CREATINE PHOSPHOKINASE INCREASED | 8 0.08 11.32 BLOOD CREATININE ABNORMAL | 1 0.01 11.33 BLOOD CREATININE INCREASED | 16 0.16 11.49 BLOOD DISORDER | 2 0.02 11.51 BLOOD ELECTROLYTES DECREASED | 1 0.01 11.52 BLOOD GASES ABNORMAL | 1 0.01 11.53 BLOOD GLUCOSE DECREASED | 8 0.08 11.61 BLOOD GLUCOSE FLUCTUATION | 2 0.02 11.63 BLOOD GLUCOSE INCREASED | 26 0.26 11.89 BLOOD IMMUNOGLOBULIN A DECREASED | 1 0.01 11.90 BLOOD IRON DECREASED | 3 0.03 11.93 BLOOD IRON INCREASED | 1 0.01 11.94 BLOOD LACTATE DEHYDROGENASE ABNORMAL | 1 0.01 11.95 BLOOD LACTATE DEHYDROGENASE DECREASED | 1 0.01 11.96 BLOOD LACTATE DEHYDROGENASE INCREASED | 4 0.04 12.00 BLOOD OSMOLARITY DECREASED | 1 0.01 12.01 BLOOD PH DECREASED | 1 0.01 12.02 BLOOD PHOSPHORUS DECREASED | 1 0.01 12.03 BLOOD PHOSPHORUS INCREASED | 1 0.01 12.04 BLOOD POTASSIUM DECREASED | 7 0.07 12.11 BLOOD POTASSIUM INCREASED | 4 0.04 12.15 BLOOD PRESSURE AMBULATORY INCREASED | 1 0.01 12.16 BLOOD PRESSURE DECREASED | 16 0.16 12.32 BLOOD PRESSURE FLUCTUATION | 4 0.04 12.36 BLOOD PRESSURE INADEQUATELY CONTROLLED | 4 0.04 12.40 BLOOD PRESSURE INCREASED | 23 0.23 12.63 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 12.64 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 12.65 BLOOD PROLACTIN INCREASED | 1 0.01 12.66 BLOOD SODIUM DECREASED | 4 0.04 12.70 BLOOD TEST ABNORMAL | 1 0.01 12.71 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 12.72 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 12.76 BLOOD UREA ABNORMAL | 1 0.01 12.77 BLOOD UREA INCREASED | 5 0.05 12.82 BLOOD URIC ACID INCREASED | 1 0.01 12.83 BLOOD URINE PRESENT | 1 0.01 12.84 BLOODY DISCHARGE | 1 0.01 12.85 BLUE TOE SYNDROME | 1 0.01 12.86 BODY HEIGHT DECREASED | 1 0.01 12.87 BODY TEMPERATURE DECREASED | 4 0.04 12.91 BODY TEMPERATURE INCREASED | 3 0.03 12.94 BONE CYST | 1 0.01 12.95 BONE DEBRIDEMENT | 3 0.03 12.98 BONE DENSITY DECREASED | 5 0.05 13.03 BONE DISORDER | 14 0.14 13.17 BONE EROSION | 1 0.01 13.18 BONE FRAGMENTATION | 1 0.01 13.19 BONE GRAFT | 1 0.01 13.20 BONE LESION | 8 0.08 13.28 BONE MARROW DISORDER | 2 0.02 13.30 BONE MARROW FAILURE | 5 0.05 13.35 BONE MARROW NECROSIS | 1 0.01 13.36 BONE MARROW RETICULIN FIBROSIS | 1 0.01 13.37 BONE MARROW TRANSPLANT | 1 0.01 13.38 BONE NEOPLASM MALIGNANT | 2 0.02 13.40 BONE OEDEMA | 1 0.01 13.41 BONE OPERATION | 2 0.02 13.43 BONE PAIN | 12 0.12 13.55 BRADYARRHYTHMIA | 1 0.01 13.56 BRADYCARDIA | 8 0.08 13.64 BRADYPHRENIA | 2 0.02 13.66 BRADYPNOEA | 1 0.01 13.67 BRAIN CANCER METASTATIC | 1 0.01 13.68 BRAIN DEATH | 1 0.01 13.69 BRAIN MIDLINE SHIFT | 1 0.01 13.70 BRAIN NEOPLASM | 1 0.01 13.71 BRAIN OEDEMA | 3 0.03 13.74 BRAIN STEM HAEMORRHAGE | 1 0.01 13.75 BRAIN STEM STROKE | 1 0.01 13.76 BREAST CANCER | 15 0.15 13.91 BREAST CANCER FEMALE | 3 0.03 13.94 BREAST CANCER IN SITU | 1 0.01 13.95 BREAST CANCER METASTATIC | 5 0.05 14.00 BREAST CANCER RECURRENT | 2 0.02 14.02 BREAST CANCER STAGE II | 1 0.01 14.03 BREAST DISORDER | 2 0.02 14.05 BREAST ENLARGEMENT | 1 0.01 14.06 BREAST INFECTION | 1 0.01 14.07 BREAST LUMP REMOVAL | 1 0.01 14.08 BREAST MASS | 4 0.04 14.12 BREAST OEDEMA | 1 0.01 14.13 BREAST OPERATION | 1 0.01 14.14 BREAST PAIN | 1 0.01 14.15 BREAST RECONSTRUCTION | 1 0.01 14.16 BREAST SWELLING | 1 0.01 14.17 BREAST TENDERNESS | 2 0.02 14.19 BREATH ODOUR | 2 0.02 14.21 BREATH SOUNDS ABNORMAL | 1 0.01 14.22 BRONCHIAL HYPERREACTIVITY | 2 0.02 14.24 BRONCHIAL OBSTRUCTION | 1 0.01 14.25 BRONCHIECTASIS | 1 0.01 14.26 BRONCHIOLITIS | 2 0.02 14.28 BRONCHITIS | 15 0.15 14.43 BRONCHOPNEUMONIA | 3 0.03 14.46 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 14.47 BRONCHOSPASM | 2 0.02 14.49 BRUXISM | 1 0.01 14.50 BUNDLE BRANCH BLOCK LEFT | 1 0.01 14.51 BUNDLE BRANCH BLOCK RIGHT | 1 0.01 14.52 BUNION | 1 0.01 14.53 BURNING SENSATION | 9 0.09 14.62 C-REACTIVE PROTEIN INCREASED | 9 0.09 14.71 CACHEXIA | 1 0.01 14.72 CALCULUS URINARY | 3 0.03 14.75 CAMPYLOBACTER INTESTINAL INFECTION | 1 0.01 14.76 CANDIDA SEPSIS | 1 0.01 14.77 CANDIDIASIS | 2 0.02 14.79 CAPILLARY LEAK SYNDROME | 1 0.01 14.80 CARCINOID TUMOUR PULMONARY | 1 0.01 14.81 CARDIAC AMYLOIDOSIS | 1 0.01 14.82 CARDIAC ARREST | 16 0.16 14.98 CARDIAC ASTHMA | 2 0.02 15.00 CARDIAC DISORDER | 21 0.21 15.21 CARDIAC FAILURE | 21 0.21 15.42 CARDIAC FAILURE CHRONIC | 1 0.01 15.43 CARDIAC FAILURE CONGESTIVE | 32 0.32 15.75 CARDIAC MALPOSITION | 1 0.01 15.76 CARDIAC MURMUR | 2 0.02 15.78 CARDIAC OPERATION | 4 0.04 15.82 CARDIAC OUTPUT DECREASED | 1 0.01 15.83 CARDIAC PACEMAKER INSERTION | 2 0.02 15.85 CARDIAC PACEMAKER REPLACEMENT | 1 0.01 15.86 CARDIAC VALVE DISEASE | 2 0.02 15.88 CARDIO-RESPIRATORY ARREST | 10 0.10 15.98 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 15.99 CARDIOGENIC SHOCK | 1 0.01 16.00 CARDIOMEGALY | 10 0.10 16.10 CARDIOMYOPATHY | 3 0.03 16.13 CARDIOPULMONARY FAILURE | 1 0.01 16.14 CARDIOTOXICITY | 2 0.02 16.16 CARDIOVASCULAR DISORDER | 3 0.03 16.19 CAROTID ARTERY DISSECTION | 1 0.01 16.20 CAROTID ARTERY OCCLUSION | 1 0.01 16.21 CAROTID ARTERY STENOSIS | 3 0.03 16.24 CAROTID ARTERY THROMBOSIS | 1 0.01 16.25 CARPAL TUNNEL SYNDROME | 1 0.01 16.26 CATARACT | 8 0.08 16.34 CATARACT NUCLEAR | 2 0.02 16.36 CATARACT OPERATION | 5 0.05 16.41 CATATONIA | 1 0.01 16.42 CATHETER PLACEMENT | 4 0.04 16.46 CATHETER REMOVAL | 1 0.01 16.47 CATHETER SITE HAEMORRHAGE | 1 0.01 16.48 CATHETER SITE INFECTION | 1 0.01 16.49 CATHETER SITE RELATED REACTION | 1 0.01 16.50 CATHETERISATION CARDIAC | 3 0.03 16.53 CAUSTIC INJURY | 1 0.01 16.54 CELL DEATH | 1 0.01 16.55 CELLULITIS | 10 0.10 16.65 CELLULITIS GANGRENOUS | 1 0.01 16.66 CENTRAL NERVOUS SYSTEM LESION | 3 0.03 16.69 CENTRAL VENOUS CATHETERISATION | 2 0.02 16.71 CEREBELLAR ATROPHY | 1 0.01 16.72 CEREBELLAR INFARCTION | 1 0.01 16.73 CEREBELLAR SYNDROME | 2 0.02 16.75 CEREBRAL ARTERY STENOSIS | 1 0.01 16.76 CEREBRAL DISORDER | 1 0.01 16.77 CEREBRAL HAEMATOMA | 1 0.01 16.78 CEREBRAL HAEMORRHAGE | 4 0.04 16.82 CEREBRAL INFARCTION | 7 0.07 16.89 CEREBRAL VENTRICLE DILATATION | 1 0.01 16.90 CEREBROVASCULAR ACCIDENT | 47 0.47 17.37 CEREBROVASCULAR SPASM | 1 0.01 17.38 CERUMEN IMPACTION | 1 0.01 17.39 CERVICAL DYSPLASIA | 1 0.01 17.40 CERVICAL POLYP | 2 0.02 17.42 CERVICAL SPINAL STENOSIS | 1 0.01 17.43 CERVICAL SPINE FLATTENING | 1 0.01 17.44 CERVICAL VERTEBRAL FRACTURE | 1 0.01 17.45 CERVIX CARCINOMA | 2 0.02 17.47 CHAPPED LIPS | 1 0.01 17.48 CHEST DISCOMFORT | 13 0.13 17.61 CHEST PAIN | 31 0.31 17.92 CHEST X-RAY ABNORMAL | 3 0.03 17.95 CHILLS | 16 0.16 18.11 CHOKING | 8 0.08 18.19 CHOLANGITIS ACUTE | 1 0.01 18.20 CHOLANGITIS SCLEROSING | 1 0.01 18.21 CHOLANGITIS SUPPURATIVE | 1 0.01 18.22 CHOLECYSTECTOMY | 8 0.08 18.30 CHOLECYSTITIS | 3 0.03 18.33 CHOLECYSTITIS ACUTE | 1 0.01 18.34 CHOLELITHIASIS | 9 0.09 18.43 CHOLESTASIS | 5 0.05 18.48 CHOLURIA | 1 0.01 18.49 CHONDROMALACIA | 1 0.01 18.50 CHOREA | 1 0.01 18.51 CHOROIDAL NEOVASCULARISATION | 1 0.01 18.52 CHROMATURIA | 4 0.04 18.56 CHRONIC FATIGUE SYNDROME | 1 0.01 18.57 CHRONIC LYMPHOCYTIC LEUKAEMIA | 4 0.04 18.61 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFO.. | 1 0.01 18.62 CHRONIC MYELOID LEUKAEMIA | 1 0.01 18.63 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 15 0.15 18.78 CHRONIC SINUSITIS | 2 0.02 18.80 CIRCULATORY COLLAPSE | 3 0.03 18.83 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 1 0.01 18.84 CIRRHOSIS ALCOHOLIC | 1 0.01 18.85 CLAVICLE FRACTURE | 2 0.02 18.87 CLONUS | 2 0.02 18.89 CLOSED FRACTURE MANIPULATION | 1 0.01 18.90 CLOSTRIDIAL INFECTION | 1 0.01 18.91 CLOSTRIDIUM DIFFICILE COLITIS | 1 0.01 18.92 COAGULOPATHY | 7 0.07 18.99 COCCIDIOIDOMYCOSIS | 1 0.01 19.00 COCCYDYNIA | 1 0.01 19.01 COELIAC DISEASE | 1 0.01 19.02 COGNITIVE DISORDER | 17 0.17 19.19 COGWHEEL RIGIDITY | 1 0.01 19.20 COLD SWEAT | 1 0.01 19.21 COLECTOMY | 2 0.02 19.23 COLECTOMY TOTAL | 1 0.01 19.24 COLITIS | 5 0.05 19.29 COLITIS ISCHAEMIC | 2 0.02 19.31 COLITIS ULCERATIVE | 8 0.08 19.39 COLLAPSE OF LUNG | 2 0.02 19.41 COLON CANCER | 3 0.03 19.44 COLON CANCER STAGE IV | 1 0.01 19.45 COLON OPERATION | 1 0.01 19.46 COLONIC POLYP | 3 0.03 19.49 COLORECTAL CANCER | 1 0.01 19.50 COLOSTOMY | 3 0.03 19.53 COMA | 10 0.10 19.63 COMMUNICATION DISORDER | 1 0.01 19.64 COMPARTMENT SYNDROME | 1 0.01 19.65 COMPLETED SUICIDE | 12 0.12 19.77 COMPLEX PARTIAL SEIZURES | 2 0.02 19.79 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 19.80 COMPLICATED MIGRAINE | 1 0.01 19.81 COMPLICATION OF PREGNANCY | 1 0.01 19.82 COMPLICATIONS OF TRANSPLANTED LIVER | 1 0.01 19.83 COMPRESSION FRACTURE | 3 0.03 19.86 COMPULSIVE SHOPPING | 2 0.02 19.88 CONCUSSION | 3 0.03 19.91 CONDITION AGGRAVATED | 23 0.23 20.14 CONDUCTIVE DEAFNESS | 2 0.02 20.16 CONFUSIONAL STATE | 41 0.41 20.57 CONGENITAL ANOMALY | 1 0.01 20.58 CONGENITAL CYSTIC KIDNEY DISEASE | 1 0.01 20.59 CONGENITAL HEART VALVE DISORDER | 1 0.01 20.60 CONGENITAL HEPATOBILIARY ANOMALY | 1 0.01 20.61 CONGENITAL TRICUSPID VALVE STENOSIS | 1 0.01 20.62 CONGESTIVE CARDIOMYOPATHY | 1 0.01 20.63 CONJUNCTIVAL PALLOR | 1 0.01 20.64 CONJUNCTIVITIS | 3 0.03 20.67 CONNECTIVE TISSUE DISORDER | 1 0.01 20.68 CONSTIPATION | 25 0.25 20.93 CONTINUOUS HAEMODIAFILTRATION | 1 0.01 20.94 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 20.95 CONTRALATERAL BREAST CANCER | 2 0.02 20.97 CONTUSION | 9 0.09 21.06 CONUS MEDULLARIS SYNDROME | 1 0.01 21.07 CONVERSION DISORDER | 1 0.01 21.08 CONVULSION | 32 0.32 21.40 COORDINATION ABNORMAL | 7 0.07 21.47 CORNEAL DYSTROPHY | 1 0.01 21.48 CORONARY ANGIOPLASTY | 1 0.01 21.49 CORONARY ARTERY BYPASS | 1 0.01 21.50 CORONARY ARTERY DISEASE | 13 0.13 21.63 CORONARY ARTERY OCCLUSION | 6 0.06 21.69 CORONARY ARTERY STENOSIS | 2 0.02 21.71 CORONARY ARTERY THROMBOSIS | 1 0.01 21.72 COSTOCHONDRITIS | 3 0.03 21.75 COUGH | 31 0.31 22.06 CRANIAL NERVE PARALYSIS | 1 0.01 22.07 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 22.08 CROHN'S DISEASE | 13 0.13 22.21 CRYING | 10 0.10 22.31 CRYOTHERAPY | 1 0.01 22.32 CRYPTOGENIC CIRRHOSIS | 1 0.01 22.33 CRYPTORCHISM | 1 0.01 22.34 CUSHING'S SYNDROME | 1 0.01 22.35 CUSHINGOID | 2 0.02 22.37 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 22.38 CUTIS LAXA | 1 0.01 22.39 CYANOSIS | 4 0.04 22.43 CYCLIC VOMITING SYNDROME | 1 0.01 22.44 CYST | 5 0.05 22.49 CYSTITIS | 12 0.12 22.61 CYSTITIS HAEMORRHAGIC | 2 0.02 22.63 CYSTOCELE | 1 0.01 22.64 CYTOLYTIC HEPATITIS | 3 0.03 22.67 CYTOMEGALOVIRUS INFECTION | 2 0.02 22.69 DACRYOCYSTITIS | 1 0.01 22.70 DACRYOSTENOSIS CONGENITAL | 1 0.01 22.71 DAWN PHENOMENON | 1 0.01 22.72 DEAFNESS | 4 0.04 22.76 DEAFNESS BILATERAL | 1 0.01 22.77 DEAFNESS NEUROSENSORY | 2 0.02 22.79 DEAFNESS TRANSITORY | 1 0.01 22.80 DEATH | 135 1.35 24.15 DEBRIDEMENT | 6 0.06 24.21 DECREASED APPETITE | 40 0.40 24.61 DECREASED IMMUNE RESPONSIVENESS | 4 0.04 24.65 DECREASED INTEREST | 4 0.04 24.69 DECUBITUS ULCER | 1 0.01 24.70 DEEP VEIN THROMBOSIS | 23 0.23 24.93 DEFORMITY | 4 0.04 24.97 DEFORMITY THORAX | 1 0.01 24.98 DEHYDRATION | 31 0.31 25.29 DELIRIUM | 5 0.05 25.34 DELUSION | 2 0.02 25.36 DELUSIONAL PERCEPTION | 1 0.01 25.37 DEMENTIA | 3 0.03 25.40 DEMYELINATION | 1 0.01 25.41 DENGUE FEVER | 1 0.01 25.42 DENTAL CARIES | 12 0.12 25.54 DENTAL DISCOMFORT | 1 0.01 25.55 DENTAL FISTULA | 1 0.01 25.56 DENTAL PROSTHESIS PLACEMENT | 1 0.01 25.57 DENTURE WEARER | 1 0.01 25.58 DEPENDENCE | 2 0.02 25.60 DEPRESSED LEVEL OF CONSCIOUSNESS | 9 0.09 25.69 DEPRESSED MOOD | 7 0.07 25.76 DEPRESSION | 59 0.59 26.35 DEPRESSIVE SYMPTOM | 1 0.01 26.36 DERMATITIS | 4 0.04 26.40 DERMATITIS ALLERGIC | 1 0.01 26.41 DERMATITIS BULLOUS | 6 0.06 26.47 DERMATITIS CONTACT | 4 0.04 26.51 DERMATITIS EXFOLIATIVE | 2 0.02 26.53 DERMATITIS PSORIASIFORM | 4 0.04 26.57 DERMATOMYOSITIS | 1 0.01 26.58 DEVICE BREAKAGE | 1 0.01 26.59 DEVICE DISLOCATION | 2 0.02 26.61 DEVICE EXPULSION | 3 0.03 26.64 DEVICE FAILURE | 1 0.01 26.65 DEVICE INTERACTION | 1 0.01 26.66 DEVICE LEAKAGE | 1 0.01 26.67 DEVICE MALFUNCTION | 11 0.11 26.78 DEVICE OCCLUSION | 1 0.01 26.79 DEVICE RELATED INFECTION | 10 0.10 26.89 DIABETES INSIPIDUS | 1 0.01 26.90 DIABETES MELLITUS | 15 0.15 27.05 DIABETES MELLITUS INADEQUATE CONTROL | 1 0.01 27.06 DIABETIC COMA | 1 0.01 27.07 DIABETIC COMPLICATION | 1 0.01 27.08 DIABETIC FOOT | 1 0.01 27.09 DIABETIC KETOACIDOSIS | 3 0.03 27.12 DIABETIC NEPHROPATHY | 1 0.01 27.13 DIABETIC NEUROPATHY | 2 0.02 27.15 DIABETIC RETINOPATHY | 1 0.01 27.16 DIALYSIS | 3 0.03 27.19 DIAPHRAGMATIC APLASIA | 1 0.01 27.20 DIAPHRAGMATIC HERNIA | 2 0.02 27.22 DIARRHOEA | 88 0.88 28.10 DIARRHOEA HAEMORRHAGIC | 1 0.01 28.11 DIFFUSE LARGE B-CELL LYMPHOMA | 2 0.02 28.13 DILATATION VENTRICULAR | 1 0.01 28.14 DIPLEGIA | 1 0.01 28.15 DIPLOPIA | 4 0.04 28.19 DISABILITY | 2 0.02 28.21 DISCOMFORT | 9 0.09 28.30 DISEASE COMPLICATION | 1 0.01 28.31 DISEASE PROGRESSION | 16 0.16 28.47 DISEASE RECURRENCE | 5 0.05 28.52 DISORIENTATION | 7 0.07 28.59 DISSEMINATED INTRAVASCULAR COAGULATION | 10 0.10 28.69 DISSEMINATED TUBERCULOSIS | 2 0.02 28.71 DISSOCIATIVE IDENTITY DISORDER | 1 0.01 28.72 DISTRACTIBILITY | 1 0.01 28.73 DISTURBANCE IN ATTENTION | 9 0.09 28.82 DIVERTICULAR PERFORATION | 2 0.02 28.84 DIVERTICULITIS | 7 0.07 28.91 DIVERTICULUM | 3 0.03 28.94 DIZZINESS | 60 0.60 29.54 DIZZINESS POSTURAL | 1 0.01 29.55 DREAMY STATE | 1 0.01 29.56 DRUG ABUSE | 6 0.06 29.62 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 2 0.02 29.64 DRUG ADMINISTRATION ERROR | 7 0.07 29.71 DRUG DEPENDENCE | 16 0.16 29.87 DRUG DISPENSING ERROR | 5 0.05 29.92 DRUG DOSE OMISSION | 7 0.07 29.99 DRUG EFFECT DECREASED | 8 0.08 30.07 DRUG EXPOSURE BEFORE PREGNANCY | 1 0.01 30.08 DRUG EXPOSURE DURING PREGNANCY | 35 0.35 30.43 DRUG EXPOSURE VIA BREAST MILK | 2 0.02 30.45 DRUG HYPERSENSITIVITY | 10 0.10 30.55 DRUG INEFFECTIVE | 98 0.98 31.53 DRUG INTERACTION | 25 0.25 31.78 DRUG LABEL CONFUSION | 1 0.01 31.79 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 31.80 DRUG LEVEL DECREASED | 2 0.02 31.82 DRUG LEVEL INCREASED | 2 0.02 31.84 DRUG PRESCRIBING ERROR | 2 0.02 31.86 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 4 0.04 31.90 DRUG RESISTANCE | 3 0.03 31.93 DRUG SPECIFIC ANTIBODY PRESENT | 3 0.03 31.96 DRUG THERAPEUTIC INCOMPATIBILITY | 1 0.01 31.97 DRUG TOLERANCE | 1 0.01 31.98 DRUG TOXICITY | 12 0.12 32.10 DRUG WITHDRAWAL CONVULSIONS | 1 0.01 32.11 DRUG WITHDRAWAL SYNDROME | 10 0.10 32.21 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 32.23 DRY EYE | 3 0.03 32.26 DRY MOUTH | 7 0.07 32.33 DRY SKIN | 4 0.04 32.37 DRY THROAT | 2 0.02 32.39 DUODENAL PERFORATION | 1 0.01 32.40 DYSAESTHESIA | 1 0.01 32.41 DYSARTHRIA | 5 0.05 32.46 DYSGEUSIA | 4 0.04 32.50 DYSGRAPHIA | 4 0.04 32.54 DYSKINESIA | 16 0.16 32.70 DYSLALIA | 1 0.01 32.71 DYSMENORRHOEA | 1 0.01 32.72 DYSPEPSIA | 10 0.10 32.82 DYSPHAGIA | 21 0.21 33.03 DYSPHEMIA | 2 0.02 33.05 DYSPHONIA | 11 0.11 33.16 DYSPHORIA | 2 0.02 33.18 DYSPLASIA | 1 0.01 33.19 DYSPNOEA | 92 0.92 34.11 DYSPNOEA EXERTIONAL | 5 0.05 34.16 DYSSTASIA | 5 0.05 34.21 DYSTONIA | 3 0.03 34.24 DYSURIA | 13 0.13 34.37 EAR INFECTION | 2 0.02 34.39 EAR PAIN | 6 0.06 34.45 EAR PRURITUS | 1 0.01 34.46 EATING DISORDER | 3 0.03 34.49 ECCHYMOSIS | 2 0.02 34.51 ECHOCARDIOGRAM ABNORMAL | 1 0.01 34.52 ECONOMIC PROBLEM | 2 0.02 34.54 ECTOPIC PREGNANCY | 2 0.02 34.56 ECZEMA | 4 0.04 34.60 EDENTULOUS | 2 0.02 34.62 EJECTION FRACTION DECREASED | 2 0.02 34.64 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 34.65 ELECTROCARDIOGRAM POOR R-WAVE PROGRES.. | 1 0.01 34.66 ELECTROCARDIOGRAM Q WAVE ABNORMAL | 1 0.01 34.67 ELECTROCARDIOGRAM QT PROLONGED | 1 0.01 34.68 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 34.69 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 34.70 ELECTROCARDIOGRAM T WAVE AMPLITUDE DE.. | 1 0.01 34.71 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 34.72 ELECTROENCEPHALOGRAM ABNORMAL | 2 0.02 34.74 ELECTROLYTE IMBALANCE | 4 0.04 34.78 ELEVATED MOOD | 1 0.01 34.79 EMBOLISM VENOUS | 1 0.01 34.80 EMERGENCY CARE | 1 0.01 34.81 EMERGENCY CARE EXAMINATION | 1 0.01 34.82 EMOTIONAL DISORDER | 2 0.02 34.84 EMOTIONAL DISTRESS | 11 0.11 34.95 EMPHYSEMA | 3 0.03 34.98 EMPTY SELLA SYNDROME | 1 0.01 34.99 EMPYEMA | 1 0.01 35.00 ENCEPHALOPATHY | 4 0.04 35.04 ENDOCARDITIS | 1 0.01 35.05 ENDODONTIC PROCEDURE | 1 0.01 35.06 ENDOMETRIAL CANCER STAGE I | 1 0.01 35.07 ENDOMETRIOSIS | 2 0.02 35.09 ENDOTRACHEAL INTUBATION | 2 0.02 35.11 ENTEROCOCCAL INFECTION | 2 0.02 35.13 ENTEROCOCCAL SEPSIS | 1 0.01 35.14 ENTEROCUTANEOUS FISTULA | 1 0.01 35.15 EOSINOPHIL COUNT INCREASED | 2 0.02 35.17 EOSINOPHILIA | 4 0.04 35.21 EOSINOPHILIC PNEUMONIA | 2 0.02 35.23 EOSINOPHILIC PNEUMONIA ACUTE | 1 0.01 35.24 EPICONDYLITIS | 1 0.01 35.25 EPIDERMAL NECROSIS | 1 0.01 35.26 EPIDERMOLYSIS | 1 0.01 35.27 EPIGLOTTITIS | 2 0.02 35.29 EPILEPSY | 9 0.09 35.38 EPISTAXIS | 12 0.12 35.50 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 2 0.02 35.52 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 35.54 ERECTILE DYSFUNCTION | 6 0.06 35.60 EROTOMANIC DELUSION | 1 0.01 35.61 ERYTHEMA | 30 0.30 35.91 ERYTHEMA MULTIFORME | 2 0.02 35.93 ERYTHEMA NODOSUM | 1 0.01 35.94 ERYTHEMA OF EYELID | 3 0.03 35.97 ESCHAR | 1 0.01 35.98 ESCHERICHIA INFECTION | 2 0.02 36.00 EUPHORIC MOOD | 3 0.03 36.03 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 36.04 EWING'S SARCOMA | 1 0.01 36.05 EXCESSIVE EYE BLINKING | 1 0.01 36.06 EXCESSIVE GRANULATION TISSUE | 2 0.02 36.08 EXCORIATION | 4 0.04 36.12 EXOMPHALOS | 1 0.01 36.13 EXOPHTHALMOS | 1 0.01 36.14 EXOSTOSIS | 5 0.05 36.19 EXPIRED DRUG ADMINISTERED | 3 0.03 36.22 EXPLORATIVE LAPAROTOMY | 1 0.01 36.23 EXPOSURE TO CONTAMINATED DEVICE | 3 0.03 36.26 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 36.27 EXTENSOR PLANTAR RESPONSE | 1 0.01 36.28 EXTERNAL EAR DISORDER | 1 0.01 36.29 EXTRADURAL ABSCESS | 1 0.01 36.30 EXTRAPYRAMIDAL DISORDER | 2 0.02 36.32 EXTRASYSTOLES | 1 0.01 36.33 EYE DISCHARGE | 2 0.02 36.35 EYE DISORDER | 3 0.03 36.38 EYE HAEMORRHAGE | 4 0.04 36.42 EYE INFECTION | 3 0.03 36.45 EYE INFECTION BACTERIAL | 1 0.01 36.46 EYE INJURY | 1 0.01 36.47 EYE IRRITATION | 4 0.04 36.51 EYE LASER SCAR | 1 0.01 36.52 EYE LASER SURGERY | 1 0.01 36.53 EYE MOVEMENT DISORDER | 1 0.01 36.54 EYE OEDEMA | 1 0.01 36.55 EYE OPERATION | 1 0.01 36.56 EYE PAIN | 3 0.03 36.59 EYE ROLLING | 1 0.01 36.60 EYE SWELLING | 8 0.08 36.68 EYELID DISORDER | 2 0.02 36.70 EYELID OEDEMA | 1 0.01 36.71 FACE OEDEMA | 5 0.05 36.76 FACET JOINT SYNDROME | 1 0.01 36.77 FACIAL BONES FRACTURE | 3 0.03 36.80 FACIAL NEURALGIA | 1 0.01 36.81 FACIAL PAIN | 2 0.02 36.83 FACIAL PALSY | 2 0.02 36.85 FACIAL PARESIS | 2 0.02 36.87 FAECAL INCONTINENCE | 1 0.01 36.88 FAECES DISCOLOURED | 5 0.05 36.93 FAECES HARD | 1 0.01 36.94 FAILURE OF CHILD RESISTANT MECHANISM .. | 1 0.01 36.95 FAILURE TO THRIVE | 2 0.02 36.97 FALL | 96 0.96 37.93 FAMILY STRESS | 1 0.01 37.94 FASCIITIS | 1 0.01 37.95 FAT EMBOLISM | 1 0.01 37.96 FAT TISSUE INCREASED | 2 0.02 37.98 FATIGUE | 112 1.12 39.10 FEAR | 4 0.04 39.14 FEAR OF DEATH | 1 0.01 39.15 FEAR OF NEEDLES | 1 0.01 39.16 FEBRILE BONE MARROW APLASIA | 1 0.01 39.17 FEBRILE CONVULSION | 2 0.02 39.19 FEBRILE NEUTROPENIA | 15 0.15 39.34 FEEDING DISORDER | 1 0.01 39.35 FEELING ABNORMAL | 26 0.26 39.61 FEELING COLD | 6 0.06 39.67 FEELING DRUNK | 1 0.01 39.68 FEELING GUILTY | 1 0.01 39.69 FEELING HOT | 5 0.05 39.74 FEELING JITTERY | 1 0.01 39.75 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 39.76 FEELING OF DESPAIR | 2 0.02 39.78 FEMALE ORGASMIC DISORDER | 1 0.01 39.79 FEMORAL ARTERY EMBOLISM | 1 0.01 39.80 FEMORAL NECK FRACTURE | 1 0.01 39.81 FEMUR FRACTURE | 13 0.13 39.94 FIBROCYSTIC BREAST DISEASE | 2 0.02 39.96 FIBROMYALGIA | 5 0.05 40.01 FIBROSIS | 3 0.03 40.04 FIBROUS HISTIOCYTOMA | 1 0.01 40.05 FIBULA FRACTURE | 2 0.02 40.07 FINGER AMPUTATION | 1 0.01 40.08 FISTULA | 4 0.04 40.12 FISTULA DISCHARGE | 4 0.04 40.16 FLATULENCE | 4 0.04 40.20 FLUID INTAKE REDUCED | 5 0.05 40.25 FLUID OVERLOAD | 3 0.03 40.28 FLUID RETENTION | 9 0.09 40.37 FLUSHING | 7 0.07 40.44 FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 1 0.01 40.45 FOETAL ANTICONVULSANT SYNDROME | 1 0.01 40.46 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR .. | 1 0.01 40.47 FOLLICULITIS | 1 0.01 40.48 FOOD AVERSION | 1 0.01 40.49 FOOD INTOLERANCE | 1 0.01 40.50 FOOT DEFORMITY | 1 0.01 40.51 FOOT FRACTURE | 4 0.04 40.55 FOREIGN BODY | 1 0.01 40.56 FORMICATION | 2 0.02 40.58 FRACTURE | 5 0.05 40.63 FRACTURE DELAYED UNION | 1 0.01 40.64 FRACTURE NONUNION | 1 0.01 40.65 FRACTURED SACRUM | 1 0.01 40.66 FREQUENT BOWEL MOVEMENTS | 2 0.02 40.68 FRUSTRATION | 1 0.01 40.69 FULL BLOOD COUNT ABNORMAL | 1 0.01 40.70 FULL BLOOD COUNT DECREASED | 1 0.01 40.71 FUNGAL INFECTION | 6 0.06 40.77 FUNGAL PERITONITIS | 2 0.02 40.79 FUNGAL TEST POSITIVE | 1 0.01 40.80 FURUNCLE | 1 0.01 40.81 GAIT DISTURBANCE | 55 0.55 41.36 GALACTORRHOEA | 2 0.02 41.38 GALLBLADDER CANCER | 1 0.01 41.39 GALLBLADDER CANCER METASTATIC | 1 0.01 41.40 GALLBLADDER CANCER STAGE III | 1 0.01 41.41 GALLBLADDER DISORDER | 8 0.08 41.49 GALLBLADDER INJURY | 2 0.02 41.51 GALLBLADDER NON-FUNCTIONING | 1 0.01 41.52 GALLBLADDER OPERATION | 1 0.01 41.53 GALLBLADDER PAIN | 1 0.01 41.54 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 8 0.08 41.62 GANGRENE | 2 0.02 41.64 GASTRIC BYPASS | 2 0.02 41.66 GASTRIC CANCER | 1 0.01 41.67 GASTRIC DISORDER | 2 0.02 41.69 GASTRIC HAEMORRHAGE | 1 0.01 41.70 GASTRIC INFECTION | 1 0.01 41.71 GASTRIC LAVAGE | 1 0.01 41.72 GASTRIC PH DECREASED | 1 0.01 41.73 GASTRIC ULCER | 9 0.09 41.82 GASTRIC ULCER HAEMORRHAGE | 2 0.02 41.84 GASTRITIS | 5 0.05 41.89 GASTRITIS EROSIVE | 1 0.01 41.90 GASTRITIS HAEMORRHAGIC | 1 0.01 41.91 GASTRODUODENAL HAEMORRHAGE | 1 0.01 41.92 GASTROENTERITIS | 8 0.08 42.00 GASTROENTERITIS NOROVIRUS | 2 0.02 42.02 GASTROENTERITIS RADIATION | 1 0.01 42.03 GASTROENTERITIS VIRAL | 2 0.02 42.05 GASTROINTESTINAL CARCINOMA | 1 0.01 42.06 GASTROINTESTINAL DISORDER | 6 0.06 42.12 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 42.13 GASTROINTESTINAL HAEMORRHAGE | 10 0.10 42.23 GASTROINTESTINAL HYPERMOTILITY | 1 0.01 42.24 GASTROINTESTINAL INFECTION | 1 0.01 42.25 GASTROINTESTINAL INFLAMMATION | 2 0.02 42.27 GASTROINTESTINAL ISCHAEMIA | 1 0.01 42.28 GASTROINTESTINAL NECROSIS | 1 0.01 42.29 GASTROINTESTINAL NEOPLASM | 1 0.01 42.30 GASTROINTESTINAL OBSTRUCTION | 1 0.01 42.31 GASTROINTESTINAL SOUNDS ABNORMAL | 2 0.02 42.33 GASTROINTESTINAL ULCER HAEMORRHAGE | 2 0.02 42.35 GASTROOESOPHAGEAL REFLUX DISEASE | 10 0.10 42.45 GASTROSPLENIC FISTULA | 1 0.01 42.46 GASTROSTOMY TUBE INSERTION | 1 0.01 42.47 GENE MUTATION IDENTIFICATION TEST POS.. | 1 0.01 42.48 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 42.49 GENERAL PHYSICAL HEALTH DETERIORATION | 17 0.17 42.66 GENERAL SYMPTOM | 7 0.07 42.73 GENERALISED OEDEMA | 3 0.03 42.76 GENITAL DISORDER FEMALE | 1 0.01 42.77 GENITAL EROSION | 3 0.03 42.80 GENITAL RASH | 1 0.01 42.81 GILBERT'S SYNDROME | 2 0.02 42.83 GINGIVAL ABSCESS | 2 0.02 42.85 GINGIVAL BLEEDING | 2 0.02 42.87 GINGIVAL DISORDER | 3 0.03 42.90 GINGIVAL HYPERPLASIA | 1 0.01 42.91 GINGIVAL INFECTION | 2 0.02 42.93 GINGIVAL OEDEMA | 1 0.01 42.94 GINGIVAL PAIN | 5 0.05 42.99 GINGIVAL RECESSION | 1 0.01 43.00 GINGIVAL ULCERATION | 1 0.01 43.01 GLAUCOMA | 3 0.03 43.04 GLAUCOMA SURGERY | 1 0.01 43.05 GLOMERULAR FILTRATION RATE DECREASED | 2 0.02 43.07 GLOMERULONEPHRITIS | 4 0.04 43.11 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 43.12 GLOMERULONEPHRITIS MINIMAL LESION | 1 0.01 43.13 GLOSSITIS | 2 0.02 43.15 GLOSSODYNIA | 6 0.06 43.21 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 43.24 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEF.. | 1 0.01 43.25 GLYCOGEN STORAGE DISEASE TYPE II | 1 0.01 43.26 GLYCOSYLATED HAEMOGLOBIN INCREASED | 4 0.04 43.30 GOITRE | 5 0.05 43.35 GOUT | 3 0.03 43.38 GRAFT VERSUS HOST DISEASE | 3 0.03 43.41 GRAND MAL CONVULSION | 9 0.09 43.50 GRANULOCYTOPENIA | 1 0.01 43.51 GRANULOMA | 3 0.03 43.54 GRIP STRENGTH DECREASED | 1 0.01 43.55 GROIN PAIN | 3 0.03 43.58 GUILLAIN-BARRE SYNDROME | 2 0.02 43.60 GUN SHOT WOUND | 1 0.01 43.61 GYNAECOMASTIA | 2 0.02 43.63 H1N1 INFLUENZA | 3 0.03 43.66 HAEMANGIOMA | 2 0.02 43.68 HAEMATEMESIS | 8 0.08 43.76 HAEMATOCHEZIA | 9 0.09 43.85 HAEMATOCRIT DECREASED | 3 0.03 43.88 HAEMATOMA | 4 0.04 43.92 HAEMATOTOXICITY | 1 0.01 43.93 HAEMATURIA | 4 0.04 43.97 HAEMOCHROMATOSIS | 1 0.01 43.98 HAEMODIALYSIS | 2 0.02 44.00 HAEMODYNAMIC INSTABILITY | 1 0.01 44.01 HAEMOGLOBIN ABNORMAL | 1 0.01 44.02 HAEMOGLOBIN DECREASED | 23 0.23 44.25 HAEMOGLOBINURIA | 1 0.01 44.26 HAEMOLYSIS | 3 0.03 44.29 HAEMOLYTIC ANAEMIA | 4 0.04 44.33 HAEMOLYTIC URAEMIC SYNDROME | 1 0.01 44.34 HAEMOPTYSIS | 3 0.03 44.37 HAEMORRHAGE | 19 0.19 44.56 HAEMORRHAGE INTRACRANIAL | 5 0.05 44.61 HAEMORRHAGIC ANAEMIA | 1 0.01 44.62 HAEMORRHAGIC STROKE | 2 0.02 44.64 HAEMORRHOID OPERATION | 1 0.01 44.65 HAEMORRHOIDAL HAEMORRHAGE | 2 0.02 44.67 HAEMORRHOIDS | 7 0.07 44.74 HAIR DISORDER | 1 0.01 44.75 HAIR GROWTH ABNORMAL | 1 0.01 44.76 HAIRY CELL LEUKAEMIA | 1 0.01 44.77 HALLUCINATION | 11 0.11 44.88 HALLUCINATION, AUDITORY | 3 0.03 44.91 HALLUCINATION, VISUAL | 6 0.06 44.97 HAND FRACTURE | 3 0.03 45.00 HAND-FOOT-AND-MOUTH DISEASE | 1 0.01 45.01 HEAD CIRCUMFERENCE ABNORMAL | 1 0.01 45.02 HEAD DEFORMITY | 1 0.01 45.03 HEAD INJURY | 5 0.05 45.08 HEADACHE | 88 0.88 45.96 HEARING IMPAIRED | 4 0.04 46.00 HEART INJURY | 6 0.06 46.06 HEART RATE DECREASED | 4 0.04 46.10 HEART RATE INCREASED | 17 0.17 46.27 HEART RATE IRREGULAR | 8 0.08 46.35 HEAT STROKE | 2 0.02 46.37 HEMIPARESIS | 3 0.03 46.40 HEMIPLEGIA | 2 0.02 46.42 HENOCH-SCHONLEIN PURPURA | 1 0.01 46.43 HEPATIC ATROPHY | 1 0.01 46.44 HEPATIC CANCER METASTATIC | 1 0.01 46.45 HEPATIC CIRRHOSIS | 6 0.06 46.51 HEPATIC CONGESTION | 1 0.01 46.52 HEPATIC CYST | 2 0.02 46.54 HEPATIC DISPLACEMENT | 1 0.01 46.55 HEPATIC ENCEPHALOPATHY | 4 0.04 46.59 HEPATIC ENZYME ABNORMAL | 2 0.02 46.61 HEPATIC ENZYME INCREASED | 12 0.12 46.73 HEPATIC FAILURE | 9 0.09 46.82 HEPATIC FIBROSIS | 1 0.01 46.83 HEPATIC FUNCTION ABNORMAL | 14 0.14 46.97 HEPATIC MASS | 1 0.01 46.98 HEPATIC NECROSIS | 3 0.03 47.01 HEPATIC NEOPLASM MALIGNANT | 1 0.01 47.02 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 47.03 HEPATIC PAIN | 1 0.01 47.04 HEPATIC STEATOSIS | 5 0.05 47.09 HEPATITIS | 3 0.03 47.12 HEPATITIS ACUTE | 1 0.01 47.13 HEPATITIS B | 3 0.03 47.16 HEPATITIS B DNA INCREASED | 2 0.02 47.18 HEPATITIS C | 12 0.12 47.30 HEPATITIS C POSITIVE | 1 0.01 47.31 HEPATITIS CHOLESTATIC | 1 0.01 47.32 HEPATITIS FULMINANT | 1 0.01 47.33 HEPATITIS TOXIC | 1 0.01 47.34 HEPATOCELLULAR INJURY | 2 0.02 47.36 HEPATOMEGALY | 7 0.07 47.43 HEPATORENAL SYNDROME | 1 0.01 47.44 HEPATOSPLENIC T-CELL LYMPHOMA | 2 0.02 47.46 HEPATOSPLENOMEGALY | 2 0.02 47.48 HEPATOTOXICITY | 2 0.02 47.50 HERNIA | 2 0.02 47.52 HERNIA REPAIR | 3 0.03 47.55 HERPES OPHTHALMIC | 1 0.01 47.56 HERPES SIMPLEX | 2 0.02 47.58 HERPES SIMPLEX SEROLOGY POSITIVE | 1 0.01 47.59 HERPES VIRUS INFECTION | 1 0.01 47.60 HERPES ZOSTER | 15 0.15 47.75 HIATUS HERNIA | 5 0.05 47.80 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 47.82 HIP ARTHROPLASTY | 3 0.03 47.85 HIP FRACTURE | 16 0.16 48.01 HIP SURGERY | 1 0.01 48.02 HISTIOCYTIC MEDULLARY RETICULOSIS | 1 0.01 48.03 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 48.05 HIV INFECTION | 2 0.02 48.07 HODGKIN'S DISEASE | 1 0.01 48.08 HOMICIDAL IDEATION | 2 0.02 48.10 HOMICIDE | 1 0.01 48.11 HORDEOLUM | 1 0.01 48.12 HOSPITALISATION | 11 0.11 48.23 HOSTILITY | 4 0.04 48.27 HOT FLUSH | 6 0.06 48.33 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 48.34 HUMERUS FRACTURE | 1 0.01 48.35 HUNGER | 2 0.02 48.37 HYDROCEPHALUS | 1 0.01 48.38 HYPERACUSIS | 1 0.01 48.39 HYPERAESTHESIA | 2 0.02 48.41 HYPERAMMONAEMIA | 1 0.01 48.42 HYPERBARIC OXYGEN THERAPY | 3 0.03 48.45 HYPERBILIRUBINAEMIA | 3 0.03 48.48 HYPERCALCAEMIA | 3 0.03 48.51 HYPERCAPNIA | 1 0.01 48.52 HYPERCHOLESTEROLAEMIA | 3 0.03 48.55 HYPERCOAGULATION | 1 0.01 48.56 HYPERGLYCAEMIA | 9 0.09 48.65 HYPERHIDROSIS | 17 0.17 48.82 HYPERKALAEMIA | 7 0.07 48.89 HYPERKERATOSIS | 2 0.02 48.91 HYPERLIPIDAEMIA | 5 0.05 48.96 HYPERPROLACTINAEMIA | 1 0.01 48.97 HYPERPYREXIA | 2 0.02 48.99 HYPERREFLEXIA | 1 0.01 49.00 HYPERSENSITIVITY | 36 0.36 49.36 HYPERSOMNIA | 3 0.03 49.39 HYPERTENSION | 46 0.46 49.85 HYPERTENSIVE CRISIS | 2 0.02 49.87 HYPERTHERMIA | 2 0.02 49.89 HYPERTHERMIA MALIGNANT | 1 0.01 49.90 HYPERTHYROIDISM | 1 0.01 49.91 HYPERTONIC BLADDER | 2 0.02 49.93 HYPERTRANSAMINASAEMIA | 1 0.01 49.94 HYPERTRICHOSIS | 3 0.03 49.97 HYPOACUSIS | 3 0.03 50.00 HYPOAESTHESIA | 38 0.38 50.38 HYPOAESTHESIA FACIAL | 3 0.03 50.41 HYPOAESTHESIA ORAL | 3 0.03 50.44 HYPOALBUMINAEMIA | 4 0.04 50.48 HYPOCALCAEMIA | 2 0.02 50.50 HYPOCHROMASIA | 1 0.01 50.51 HYPOGLYCAEMIA | 10 0.10 50.61 HYPOGLYCAEMIC COMA | 2 0.02 50.63 HYPOKALAEMIA | 9 0.09 50.72 HYPOKINESIA | 2 0.02 50.74 HYPOMAGNESAEMIA | 2 0.02 50.76 HYPOMANIA | 4 0.04 50.80 HYPOMENORRHOEA | 1 0.01 50.81 HYPONATRAEMIA | 17 0.17 50.98 HYPOPHAGIA | 12 0.12 51.10 HYPOPHARYNGEAL CANCER | 1 0.01 51.11 HYPOPHOSPHATAEMIA | 2 0.02 51.13 HYPOPLASTIC RIGHT HEART SYNDROME | 1 0.01 51.14 HYPOPROTEINAEMIA | 1 0.01 51.15 HYPOTENSION | 26 0.26 51.41 HYPOTHERMIA | 2 0.02 51.43 HYPOTHYROIDISM | 12 0.12 51.55 HYPOTONIA | 2 0.02 51.57 HYPOVOLAEMIA | 1 0.01 51.58 HYPOVOLAEMIC SHOCK | 2 0.02 51.60 HYPOXIA | 6 0.06 51.66 HYSTERECTOMY | 7 0.07 51.73 IDIOSYNCRATIC DRUG REACTION | 1 0.01 51.74 IGA NEPHROPATHY | 1 0.01 51.75 ILEECTOMY | 1 0.01 51.76 ILEOSTOMY | 1 0.01 51.77 ILEUS | 2 0.02 51.79 ILEUS PARALYTIC | 2 0.02 51.81 ILL-DEFINED DISORDER | 1 0.01 51.82 IMMEDIATE POST-INJECTION REACTION | 1 0.01 51.83 IMMOBILE | 1 0.01 51.84 IMMUNE RECONSTITUTION SYNDROME | 6 0.06 51.90 IMMUNE SYSTEM DISORDER | 4 0.04 51.94 IMMUNODEFICIENCY | 1 0.01 51.95 IMPAIRED DRIVING ABILITY | 5 0.05 52.00 IMPAIRED HEALING | 17 0.17 52.17 IMPAIRED WORK ABILITY | 2 0.02 52.19 IMPETIGO | 1 0.01 52.20 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 52.21 IMPULSE-CONTROL DISORDER | 2 0.02 52.23 IMPULSIVE BEHAVIOUR | 1 0.01 52.24 IN-STENT CORONARY ARTERY RESTENOSIS | 1 0.01 52.25 INADEQUATE ANALGESIA | 1 0.01 52.26 INADEQUATE DIET | 3 0.03 52.29 INADEQUATE LUBRICATION | 1 0.01 52.30 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 52.32 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 9 0.09 52.41 INCISION SITE ABSCESS | 1 0.01 52.42 INCISION SITE HAEMORRHAGE | 1 0.01 52.43 INCISION SITE INFECTION | 1 0.01 52.44 INCISIONAL DRAINAGE | 1 0.01 52.45 INCISIONAL HERNIA | 1 0.01 52.46 INCOHERENT | 1 0.01 52.47 INCONTINENCE | 3 0.03 52.50 INCORRECT DOSE ADMINISTERED | 6 0.06 52.56 INCORRECT DRUG ADMINISTRATION DURATION | 1 0.01 52.57 INCORRECT DRUG DOSAGE FORM ADMINISTERED | 3 0.03 52.60 INCORRECT ROUTE OF DRUG ADMINISTRATION | 10 0.10 52.70 INCREASED TENDENCY TO BRUISE | 5 0.05 52.75 INCREASED UPPER AIRWAY SECRETION | 4 0.04 52.79 INDURATION | 1 0.01 52.80 INFECTED BITES | 1 0.01 52.81 INFECTED CYST | 1 0.01 52.82 INFECTION | 23 0.23 53.05 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 53.06 INFECTION SUSCEPTIBILITY INCREASED | 1 0.01 53.07 INFECTIOUS MONONUCLEOSIS | 1 0.01 53.08 INFECTIVE EXACERBATION OF CHRONIC OBS.. | 1 0.01 53.09 INFERTILITY | 1 0.01 53.10 INFLAMMATION | 7 0.07 53.17 INFLAMMATORY BOWEL DISEASE | 5 0.05 53.22 INFLUENZA | 8 0.08 53.30 INFLUENZA LIKE ILLNESS | 37 0.37 53.67 INFUSION RELATED REACTION | 12 0.12 53.79 INFUSION SITE EXTRAVASATION | 1 0.01 53.80 INFUSION SITE HAEMATOMA | 2 0.02 53.82 INFUSION SITE INFLAMMATION | 1 0.01 53.83 INFUSION SITE PAIN | 2 0.02 53.85 INFUSION SITE PARAESTHESIA | 1 0.01 53.86 INFUSION SITE REACTION | 1 0.01 53.87 INFUSION SITE SWELLING | 1 0.01 53.88 INITIAL INSOMNIA | 1 0.01 53.89 INJECTION SITE ANAESTHESIA | 1 0.01 53.90 INJECTION SITE ERYTHEMA | 3 0.03 53.93 INJECTION SITE HAEMATOMA | 5 0.05 53.98 INJECTION SITE HAEMORRHAGE | 5 0.05 54.03 INJECTION SITE INDURATION | 1 0.01 54.04 INJECTION SITE INJURY | 1 0.01 54.05 INJECTION SITE MASS | 1 0.01 54.06 INJECTION SITE NECROSIS | 2 0.02 54.08 INJECTION SITE PAIN | 10 0.10 54.18 INJECTION SITE REACTION | 3 0.03 54.21 INJECTION SITE SWELLING | 1 0.01 54.22 INJECTION SITE VASCULITIS | 1 0.01 54.23 INJURY | 11 0.11 54.34 INJURY ASSOCIATED WITH DEVICE | 4 0.04 54.38 INSOMNIA | 43 0.43 54.81 INTENTIONAL DRUG MISUSE | 8 0.08 54.89 INTENTIONAL OVERDOSE | 8 0.08 54.97 INTENTIONAL SELF-INJURY | 4 0.04 55.01 INTERCEPTED MEDICATION ERROR | 1 0.01 55.02 INTERMITTENT CLAUDICATION | 1 0.01 55.03 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 55.04 INTERNATIONAL NORMALISED RATIO INCREA.. | 14 0.14 55.18 INTERSTITIAL LUNG DISEASE | 9 0.09 55.27 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 55.28 INTERVERTEBRAL DISC DEGENERATION | 7 0.07 55.35 INTERVERTEBRAL DISC DISORDER | 1 0.01 55.36 INTERVERTEBRAL DISC INJURY | 1 0.01 55.37 INTERVERTEBRAL DISC OPERATION | 1 0.01 55.38 INTERVERTEBRAL DISC PROTRUSION | 11 0.11 55.49 INTERVERTEBRAL DISC SPACE NARROWING | 1 0.01 55.50 INTERVERTEBRAL DISCITIS | 2 0.02 55.52 INTESTINAL ADHESION LYSIS | 1 0.01 55.53 INTESTINAL HAEMORRHAGE | 1 0.01 55.54 INTESTINAL ISCHAEMIA | 1 0.01 55.55 INTESTINAL MASS | 1 0.01 55.56 INTESTINAL OBSTRUCTION | 9 0.09 55.65 INTESTINAL PERFORATION | 3 0.03 55.68 INTESTINAL RESECTION | 3 0.03 55.71 INTESTINAL STENOSIS | 1 0.01 55.72 INTRA-UTERINE DEATH | 2 0.02 55.74 INTRACARDIAC THROMBUS | 2 0.02 55.76 INTRACRANIAL PRESSURE INCREASED | 1 0.01 55.77 INTRAOCULAR PRESSURE INCREASED | 2 0.02 55.79 INVESTIGATION | 1 0.01 55.80 IRIDOCYCLITIS | 2 0.02 55.82 IRON DEFICIENCY ANAEMIA | 3 0.03 55.85 IRRITABILITY | 6 0.06 55.91 IRRITABLE BOWEL SYNDROME | 5 0.05 55.96 ISCHAEMIC STROKE | 4 0.04 56.00 JAUNDICE | 11 0.11 56.11 JAUNDICE EXTRAHEPATIC OBSTRUCTIVE | 1 0.01 56.12 JAW DISORDER | 5 0.05 56.17 JAW FRACTURE | 4 0.04 56.21 JAW OPERATION | 4 0.04 56.25 JC VIRUS INFECTION | 1 0.01 56.26 JC VIRUS TEST POSITIVE | 2 0.02 56.28 JOINT ARTHROPLASTY | 1 0.01 56.29 JOINT DISLOCATION | 2 0.02 56.31 JOINT EFFUSION | 2 0.02 56.33 JOINT HYPEREXTENSION | 1 0.01 56.34 JOINT INJURY | 1 0.01 56.35 JOINT RANGE OF MOTION DECREASED | 3 0.03 56.38 JOINT SPRAIN | 3 0.03 56.41 JOINT STABILISATION | 1 0.01 56.42 JOINT STIFFNESS | 2 0.02 56.44 JOINT SWELLING | 6 0.06 56.50 JUGULAR VEIN THROMBOSIS | 1 0.01 56.51 KETONURIA | 1 0.01 56.52 KIDNEY INFECTION | 6 0.06 56.58 KIDNEY TRANSPLANT REJECTION | 1 0.01 56.59 KLEBSIELLA INFECTION | 2 0.02 56.61 KNEE ARTHROPLASTY | 1 0.01 56.62 KNEE OPERATION | 2 0.02 56.64 KUSSMAUL RESPIRATION | 1 0.01 56.65 LABORATORY TEST ABNORMAL | 1 0.01 56.66 LACERATION | 1 0.01 56.67 LACRIMAL MUCOCOELE | 1 0.01 56.68 LACRIMATION INCREASED | 2 0.02 56.70 LACTASE DEFICIENCY | 1 0.01 56.71 LACTIC ACIDOSIS | 4 0.04 56.75 LARGE INTESTINE ANASTOMOSIS | 1 0.01 56.76 LARGE INTESTINE OPERATION | 1 0.01 56.77 LARGE INTESTINE PERFORATION | 2 0.02 56.79 LARYNGEAL CANCER | 1 0.01 56.80 LARYNGEAL INJURY | 1 0.01 56.81 LARYNGITIS | 2 0.02 56.83 LEFT ATRIAL DILATATION | 1 0.01 56.84 LEFT VENTRICULAR DYSFUNCTION | 2 0.02 56.86 LEFT VENTRICULAR FAILURE | 2 0.02 56.88 LEIOMYOMA | 1 0.01 56.89 LENTIGO | 1 0.01 56.90 LERICHE SYNDROME | 1 0.01 56.91 LESION EXCISION | 1 0.01 56.92 LETHARGY | 14 0.14 57.06 LEUCINE AMINOPEPTIDASE INCREASED | 1 0.01 57.07 LEUKAEMIA | 4 0.04 57.11 LEUKOCYTOSIS | 5 0.05 57.16 LEUKOENCEPHALOPATHY | 3 0.03 57.19 LEUKOPENIA | 10 0.10 57.29 LIBIDO DECREASED | 5 0.05 57.34 LIBIDO DISORDER | 1 0.01 57.35 LICHEN PLANUS | 1 0.01 57.36 LICHEN SCLEROSUS | 1 0.01 57.37 LIFE EXPECTANCY SHORTENED | 2 0.02 57.39 LIGAMENT RUPTURE | 1 0.01 57.40 LIGAMENT SPRAIN | 1 0.01 57.41 LIMB DISCOMFORT | 1 0.01 57.42 LIMB INJURY | 2 0.02 57.44 LIP DISORDER | 1 0.01 57.45 LIP DRY | 2 0.02 57.47 LIP EROSION | 2 0.02 57.49 LIP OEDEMA | 2 0.02 57.51 LIP SWELLING | 8 0.08 57.59 LIPASE INCREASED | 5 0.05 57.64 LIPIDS INCREASED | 1 0.01 57.65 LIPODYSTROPHY ACQUIRED | 2 0.02 57.67 LIPOMA | 1 0.01 57.68 LIPOSARCOMA | 1 0.01 57.69 LISTLESS | 1 0.01 57.70 LITHOTRIPSY | 1 0.01 57.71 LIVER DISORDER | 11 0.11 57.82 LIVER FUNCTION TEST ABNORMAL | 16 0.16 57.98 LIVER INJURY | 2 0.02 58.00 LIVER TRANSPLANT | 1 0.01 58.01 LIVER TRANSPLANT REJECTION | 2 0.02 58.03 LOCAL SWELLING | 2 0.02 58.05 LOCALISED INFECTION | 3 0.03 58.08 LOGORRHOEA | 1 0.01 58.09 LOOSE TOOTH | 2 0.02 58.11 LOSS OF CONSCIOUSNESS | 34 0.34 58.45 LOSS OF CONTROL OF LEGS | 5 0.05 58.50 LOSS OF LIBIDO | 2 0.02 58.52 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 58.54 LOW TURNOVER OSTEOPATHY | 2 0.02 58.56 LOWER EXTREMITY MASS | 1 0.01 58.57 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 58.58 LOWER LIMB FRACTURE | 4 0.04 58.62 LOWER RESPIRATORY TRACT INFECTION | 10 0.10 58.72 LUMBAR VERTEBRAL FRACTURE | 2 0.02 58.74 LUNG ABSCESS | 1 0.01 58.75 LUNG ADENOCARCINOMA STAGE III | 1 0.01 58.76 LUNG DISORDER | 10 0.10 58.86 LUNG INFECTION | 8 0.08 58.94 LUNG INFECTION PSEUDOMONAL | 1 0.01 58.95 LUNG INFILTRATION | 3 0.03 58.98 LUNG NEOPLASM | 2 0.02 59.00 LUNG NEOPLASM MALIGNANT | 10 0.10 59.10 LUPUS-LIKE SYNDROME | 4 0.04 59.14 LYME DISEASE | 1 0.01 59.15 LYMPH NODE TUBERCULOSIS | 1 0.01 59.16 LYMPHADENECTOMY | 1 0.01 59.17 LYMPHADENOPATHY | 9 0.09 59.26 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 59.27 LYMPHANGITIS | 1 0.01 59.28 LYMPHOCYTE COUNT DECREASED | 1 0.01 59.29 LYMPHOCYTE COUNT INCREASED | 1 0.01 59.30 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 59.31 LYMPHOEDEMA | 1 0.01 59.32 LYMPHOID TISSUE HYPERPLASIA | 1 0.01 59.33 LYMPHOMA | 6 0.06 59.39 LYMPHOPENIA | 4 0.04 59.43 MACULAR DEGENERATION | 2 0.02 59.45 MACULAR OEDEMA | 1 0.01 59.46 MACULAR SCAR | 1 0.01 59.47 MALABSORPTION | 2 0.02 59.49 MALAISE | 62 0.62 60.11 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 60.12 MALIGNANT HYPERTENSION | 1 0.01 60.13 MALIGNANT MELANOMA | 3 0.03 60.16 MALIGNANT NEOPLASM PROGRESSION | 13 0.13 60.29 MALNUTRITION | 4 0.04 60.33 MAMMOPLASTY | 1 0.01 60.34 MASS | 1 0.01 60.35 MASS EXCISION | 1 0.01 60.36 MASTECTOMY | 3 0.03 60.39 MASTICATION DISORDER | 3 0.03 60.42 MASTITIS | 1 0.01 60.43 MASTITIS BACTERIAL | 1 0.01 60.44 MASTOIDITIS | 1 0.01 60.45 MATERNAL DRUGS AFFECTING FOETUS | 2 0.02 60.47 MEAN CELL HAEMOGLOBIN | 1 0.01 60.48 MEAN CELL VOLUME INCREASED | 1 0.01 60.49 MECHANICAL VENTILATION | 4 0.04 60.53 MECONIUM STAIN | 1 0.01 60.54 MEDIASTINUM NEOPLASM | 1 0.01 60.55 MEDICAL DEVICE COMPLICATION | 4 0.04 60.59 MEDICATION ERROR | 7 0.07 60.66 MEDICATION RESIDUE | 1 0.01 60.67 MEGACOLON | 1 0.01 60.68 MELAENA | 5 0.05 60.73 MELANOCYTIC NAEVUS | 2 0.02 60.75 MEMORY IMPAIRMENT | 41 0.41 61.16 MENIERE'S DISEASE | 2 0.02 61.18 MENINGITIS | 5 0.05 61.23 MENINGOCOCCAL SEPSIS | 1 0.01 61.24 MENISCAL DEGENERATION | 1 0.01 61.25 MENISCUS LESION | 1 0.01 61.26 MENOPAUSE | 1 0.01 61.27 MENORRHAGIA | 2 0.02 61.29 MENSTRUATION DELAYED | 4 0.04 61.33 MENTAL DISORDER | 8 0.08 61.41 MENTAL IMPAIRMENT | 5 0.05 61.46 MENTAL STATUS CHANGES | 5 0.05 61.51 MESOTHELIOMA | 1 0.01 61.52 METABOLIC ACIDOSIS | 3 0.03 61.55 METABOLIC DISORDER | 2 0.02 61.57 METABOLIC FUNCTION TEST ABNORMAL | 1 0.01 61.58 METASTASES TO ADRENALS | 1 0.01 61.59 METASTASES TO BONE | 5 0.05 61.64 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 61.66 METASTASES TO LIVER | 3 0.03 61.69 METASTASES TO LUNG | 2 0.02 61.71 METASTASES TO MENINGES | 1 0.01 61.72 METASTASES TO SPINE | 1 0.01 61.73 METASTASES TO THE MEDIASTINUM | 1 0.01 61.74 METASTASIS | 1 0.01 61.75 METASTATIC MALIGNANT MELANOMA | 1 0.01 61.76 METASTATIC NEOPLASM | 2 0.02 61.78 METASTATIC PAIN | 1 0.01 61.79 METASTATIC RENAL CELL CARCINOMA | 1 0.01 61.80 MICROALBUMINURIA | 1 0.01 61.81 MIDDLE INSOMNIA | 1 0.01 61.82 MIGRAINE | 13 0.13 61.95 MILIARY PNEUMONIA | 1 0.01 61.96 MIOSIS | 1 0.01 61.97 MISCARRIAGE OF PARTNER | 1 0.01 61.98 MITOCHONDRIAL TOXICITY | 2 0.02 62.00 MITRAL VALVE DISEASE | 1 0.01 62.01 MITRAL VALVE INCOMPETENCE | 2 0.02 62.03 MITRAL VALVE PROLAPSE | 1 0.01 62.04 MITRAL VALVE REPLACEMENT | 1 0.01 62.05 MIXED LIVER INJURY | 1 0.01 62.06 MOANING | 2 0.02 62.08 MOBILITY DECREASED | 20 0.20 62.28 MONOCYTE COUNT DECREASED | 1 0.01 62.29 MONONEUROPATHY MULTIPLEX | 1 0.01 62.30 MONONUCLEOSIS SYNDROME | 1 0.01 62.31 MONOPLEGIA | 2 0.02 62.33 MOOD ALTERED | 2 0.02 62.35 MOOD DISORDER DUE TO A GENERAL MEDICA.. | 1 0.01 62.36 MOOD SWINGS | 3 0.03 62.39 MOTOR DYSFUNCTION | 2 0.02 62.41 MOTOR NEURONE DISEASE | 1 0.01 62.42 MOUTH HAEMORRHAGE | 4 0.04 62.46 MOUTH INJURY | 2 0.02 62.48 MOUTH ULCERATION | 8 0.08 62.56 MOVEMENT DISORDER | 5 0.05 62.61 MOYAMOYA DISEASE | 2 0.02 62.63 MUCOSAL EROSION | 2 0.02 62.65 MUCOSAL INFECTION | 1 0.01 62.66 MUCOSAL INFLAMMATION | 6 0.06 62.72 MULTI-ORGAN DISORDER | 2 0.02 62.74 MULTI-ORGAN FAILURE | 14 0.14 62.88 MULTIMORBIDITY | 2 0.02 62.90 MULTIPLE ALLERGIES | 2 0.02 62.92 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 62.93 MULTIPLE DRUG OVERDOSE | 1 0.01 62.94 MULTIPLE FRACTURES | 1 0.01 62.95 MULTIPLE MYELOMA | 5 0.05 63.00 MULTIPLE SCLEROSIS | 27 0.27 63.27 MULTIPLE SCLEROSIS RELAPSE | 47 0.47 63.74 MUSCLE ATROPHY | 3 0.03 63.77 MUSCLE DISORDER | 1 0.01 63.78 MUSCLE HAEMORRHAGE | 2 0.02 63.80 MUSCLE INJURY | 1 0.01 63.81 MUSCLE NECROSIS | 1 0.01 63.82 MUSCLE OPERATION | 1 0.01 63.83 MUSCLE RIGIDITY | 1 0.01 63.84 MUSCLE RUPTURE | 1 0.01 63.85 MUSCLE SPASMS | 31 0.31 64.16 MUSCLE SPASTICITY | 7 0.07 64.23 MUSCLE SWELLING | 1 0.01 64.24 MUSCLE TIGHTNESS | 4 0.04 64.28 MUSCLE TWITCHING | 4 0.04 64.32 MUSCULAR WEAKNESS | 51 0.51 64.83 MUSCULOSKELETAL CHEST PAIN | 2 0.02 64.85 MUSCULOSKELETAL DISCOMFORT | 2 0.02 64.87 MUSCULOSKELETAL DISORDER | 2 0.02 64.89 MUSCULOSKELETAL PAIN | 16 0.16 65.05 MUSCULOSKELETAL STIFFNESS | 17 0.17 65.22 MYALGIA | 28 0.28 65.50 MYCOBACTERIUM ABSCESSUS INFECTION | 1 0.01 65.51 MYDRIASIS | 1 0.01 65.52 MYELOBLAST COUNT INCREASED | 1 0.01 65.53 MYELODYSPLASTIC SYNDROME | 1 0.01 65.54 MYELODYSPLASTIC SYNDROME TRANSFORMATION | 1 0.01 65.55 MYELOMA RECURRENCE | 2 0.02 65.57 MYELOPROLIFERATIVE DISORDER | 1 0.01 65.58 MYOCARDIAL INFARCTION | 64 0.64 66.22 MYOCARDIAL ISCHAEMIA | 4 0.04 66.26 MYOCLONUS | 2 0.02 66.28 MYOFASCIAL PAIN SYNDROME | 1 0.01 66.29 MYOGLOBINURIA | 1 0.01 66.30 MYOPATHY | 5 0.05 66.35 MYOPATHY TOXIC | 1 0.01 66.36 MYOSITIS | 3 0.03 66.39 NAIL DISORDER | 1 0.01 66.40 NASAL CONGESTION | 5 0.05 66.45 NASAL DISCOMFORT | 1 0.01 66.46 NASAL OEDEMA | 1 0.01 66.47 NASAL POLYPS | 1 0.01 66.48 NASAL SEPTUM DEVIATION | 1 0.01 66.49 NASAL SEPTUM PERFORATION | 1 0.01 66.50 NASAL TURBINATE ABNORMALITY | 1 0.01 66.51 NASOPHARYNGITIS | 26 0.26 66.77 NAUSEA | 104 1.04 67.81 NECK PAIN | 16 0.16 67.97 NEONATAL ASPHYXIA | 1 0.01 67.98 NEOPLASM | 1 0.01 67.99 NEOPLASM MALIGNANT | 8 0.08 68.07 NEOPLASM PROGRESSION | 1 0.01 68.08 NEPHRITIS | 1 0.01 68.09 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 68.10 NEPHROGENIC SYSTEMIC FIBROSIS | 1 0.01 68.11 NEPHROLITHIASIS | 8 0.08 68.19 NEPHROPATHY TOXIC | 2 0.02 68.21 NEPHROTIC SYNDROME | 3 0.03 68.24 NERVE COMPRESSION | 2 0.02 68.26 NERVE ROOT COMPRESSION | 1 0.01 68.27 NERVOUS SYSTEM DISORDER | 6 0.06 68.33 NERVOUSNESS | 13 0.13 68.46 NEURALGIA | 4 0.04 68.50 NEURITIS | 2 0.02 68.52 NEURODERMATITIS | 1 0.01 68.53 NEUROGENIC BLADDER | 2 0.02 68.55 NEUROLEPTIC MALIGNANT SYNDROME | 12 0.12 68.67 NEUROLOGICAL DECOMPENSATION | 2 0.02 68.69 NEUROMYELITIS OPTICA | 1 0.01 68.70 NEUROPATHY PERIPHERAL | 8 0.08 68.78 NEUTROPENIA | 18 0.18 68.96 NEUTROPENIC INFECTION | 1 0.01 68.97 NEUTROPENIC SEPSIS | 2 0.02 68.99 NEUTROPHIL COUNT DECREASED | 2 0.02 69.01 NEUTROPHIL COUNT INCREASED | 3 0.03 69.04 NEUTROPHILIA | 1 0.01 69.05 NIGHT SWEATS | 3 0.03 69.08 NIGHTMARE | 4 0.04 69.12 NIKOLSKY'S SIGN | 2 0.02 69.14 NO ADVERSE EVENT | 21 0.21 69.35 NO THERAPEUTIC RESPONSE | 3 0.03 69.38 NOCARDIOSIS | 1 0.01 69.39 NOCTURNAL DYSPNOEA | 1 0.01 69.40 NODULE | 2 0.02 69.42 NODULE ON EXTREMITY | 1 0.01 69.43 NON-CARDIAC CHEST PAIN | 3 0.03 69.46 NON-HODGKIN'S LYMPHOMA | 2 0.02 69.48 NON-HODGKIN'S LYMPHOMA RECURRENT | 1 0.01 69.49 NON-SMALL CELL LUNG CANCER | 1 0.01 69.50 NONSPECIFIC REACTION | 2 0.02 69.52 NORMAL NEWBORN | 2 0.02 69.54 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 69.55 NOSOCOMIAL INFECTION | 3 0.03 69.58 NUCHAL RIGIDITY | 1 0.01 69.59 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 69.60 NUMB CHIN SYNDROME | 1 0.01 69.61 NYSTAGMUS | 1 0.01 69.62 OBESITY | 4 0.04 69.66 OBSESSIVE THOUGHTS | 1 0.01 69.67 OBSESSIVE-COMPULSIVE DISORDER | 1 0.01 69.68 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 69.69 OCCUPATIONAL EXPOSURE TO DRUG | 1 0.01 69.70 OCULAR HYPERAEMIA | 2 0.02 69.72 OEDEMA | 13 0.13 69.85 OEDEMA MOUTH | 5 0.05 69.90 OEDEMA MUCOSAL | 1 0.01 69.91 OEDEMA PERIPHERAL | 41 0.41 70.32 OESOPHAGEAL DILATATION | 1 0.01 70.33 OESOPHAGEAL DILATION PROCEDURE | 1 0.01 70.34 OESOPHAGEAL HAEMORRHAGE | 1 0.01 70.35 OESOPHAGEAL PAIN | 3 0.03 70.38 OESOPHAGEAL SPASM | 1 0.01 70.39 OESOPHAGEAL ULCER | 2 0.02 70.41 OESOPHAGITIS | 4 0.04 70.45 OESOPHAGOGASTRIC FUNDOPLASTY | 1 0.01 70.46 OFF LABEL USE | 18 0.18 70.64 OLIGOHYDRAMNIOS | 3 0.03 70.67 OLIGURIA | 2 0.02 70.69 ONYCHOMYCOSIS | 2 0.02 70.71 OPEN FRACTURE | 1 0.01 70.72 OPEN WOUND | 2 0.02 70.74 OPERATIVE HAEMORRHAGE | 2 0.02 70.76 OPISTHOTONUS | 1 0.01 70.77 OPPORTUNISTIC INFECTION | 1 0.01 70.78 OPTIC ATROPHY | 1 0.01 70.79 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 70.80 OPTIC NEURITIS | 7 0.07 70.87 ORAL CANDIDIASIS | 4 0.04 70.91 ORAL DISCOMFORT | 2 0.02 70.93 ORAL DISORDER | 8 0.08 71.01 ORAL FUNGAL INFECTION | 1 0.01 71.02 ORAL HERPES | 4 0.04 71.06 ORAL INFECTION | 3 0.03 71.09 ORAL MUCOSA EROSION | 2 0.02 71.11 ORAL PAIN | 6 0.06 71.17 ORAL PUSTULE | 1 0.01 71.18 ORAL SURGERY | 1 0.01 71.19 ORAL TORUS | 5 0.05 71.24 ORGAN FAILURE | 1 0.01 71.25 ORGANIC ERECTILE DYSFUNCTION | 1 0.01 71.26 OROPHARYNGEAL BLISTERING | 1 0.01 71.27 OROPHARYNGEAL PAIN | 14 0.14 71.41 OROPHARYNGEAL SPASM | 1 0.01 71.42 ORTHOSTATIC HYPERTENSION | 1 0.01 71.43 ORTHOSTATIC HYPOTENSION | 5 0.05 71.48 OSMOTIC DEMYELINATION SYNDROME | 1 0.01 71.49 OSTEITIS | 4 0.04 71.53 OSTEOARTHRITIS | 15 0.15 71.68 OSTEOLYSIS | 1 0.01 71.69 OSTEOMA | 1 0.01 71.70 OSTEOMYELITIS | 16 0.16 71.86 OSTEONECROSIS | 42 0.42 72.28 OSTEOPENIA | 7 0.07 72.35 OSTEOPOROSIS | 7 0.07 72.42 OSTEOSCLEROSIS | 1 0.01 72.43 OTITIS EXTERNA | 1 0.01 72.44 OTITIS MEDIA | 1 0.01 72.45 OVARIAN CANCER | 2 0.02 72.47 OVARIAN CYST | 7 0.07 72.54 OVARIAN CYST RUPTURED | 1 0.01 72.55 OVARIAN DISORDER | 1 0.01 72.56 OVARIAN ENLARGEMENT | 1 0.01 72.57 OVARIAN RUPTURE | 1 0.01 72.58 OVERDOSE | 26 0.26 72.84 OXYGEN SATURATION DECREASED | 5 0.05 72.89 PAIN | 69 0.69 73.58 PAIN IN EXTREMITY | 62 0.62 74.20 PAIN IN JAW | 12 0.12 74.32 PAIN OF SKIN | 3 0.03 74.35 PAINFUL DEFAECATION | 1 0.01 74.36 PALLOR | 8 0.08 74.44 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 11 0.11 74.55 PALPITATIONS | 16 0.16 74.71 PANCREATIC CARCINOMA | 4 0.04 74.75 PANCREATIC CYST | 1 0.01 74.76 PANCREATIC DISORDER | 2 0.02 74.78 PANCREATIC ENZYMES INCREASED | 1 0.01 74.79 PANCREATIC MASS | 1 0.01 74.80 PANCREATIC NEOPLASM | 1 0.01 74.81 PANCREATITIS | 15 0.15 74.96 PANCREATITIS ACUTE | 6 0.06 75.02 PANCREATITIS HAEMORRHAGIC | 1 0.01 75.03 PANCYTOPENIA | 7 0.07 75.10 PANIC ATTACK | 6 0.06 75.16 PANIC DISORDER | 1 0.01 75.17 PANIC REACTION | 1 0.01 75.18 PANNICULITIS | 2 0.02 75.20 PARAESTHESIA | 30 0.30 75.50 PARAESTHESIA ORAL | 2 0.02 75.52 PARALYSIS | 1 0.01 75.53 PARANASAL SINUS HYPERSECRETION | 1 0.01 75.54 PARANOIA | 1 0.01 75.55 PARAPLEGIA | 1 0.01 75.56 PARKINSON'S DISEASE | 2 0.02 75.58 PARKINSONISM | 2 0.02 75.60 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 1 0.01 75.61 PARTIAL SEIZURES | 2 0.02 75.63 PATELLA FRACTURE | 1 0.01 75.64 PATHOGEN RESISTANCE | 1 0.01 75.65 PATHOLOGICAL FRACTURE | 2 0.02 75.67 PATHOLOGICAL GAMBLING | 3 0.03 75.70 PELVIC DISCOMFORT | 1 0.01 75.71 PELVIC FRACTURE | 2 0.02 75.73 PELVIC NEOPLASM | 1 0.01 75.74 PELVIC PAIN | 3 0.03 75.77 PEMPHIGOID | 2 0.02 75.79 PENILE OEDEMA | 1 0.01 75.80 PERFORMANCE STATUS DECREASED | 1 0.01 75.81 PERICARDIAL EFFUSION | 5 0.05 75.86 PERICARDIAL HAEMORRHAGE | 1 0.01 75.87 PERICARDITIS | 2 0.02 75.89 PERIODONTAL DISEASE | 1 0.01 75.90 PERIODONTITIS | 2 0.02 75.92 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 75.93 PERIPHERAL COLDNESS | 3 0.03 75.96 PERIPHERAL ISCHAEMIA | 2 0.02 75.98 PERIPHERAL VASCULAR DISORDER | 3 0.03 76.01 PERIRECTAL ABSCESS | 1 0.01 76.02 PERITONEAL DIALYSIS COMPLICATION | 5 0.05 76.07 PERITONEAL FLUID ANALYSIS ABNORMAL | 1 0.01 76.08 PERITONEAL HAEMORRHAGE | 1 0.01 76.09 PERITONEAL TUBERCULOSIS | 1 0.01 76.10 PERITONITIS | 8 0.08 76.18 PERITONITIS BACTERIAL | 3 0.03 76.21 PERNICIOUS ANAEMIA | 2 0.02 76.23 PERONEAL NERVE PALSY | 2 0.02 76.25 PERSECUTORY DELUSION | 2 0.02 76.27 PERSONALITY CHANGE | 2 0.02 76.29 PERSONALITY DISORDER | 1 0.01 76.30 PETECHIAE | 6 0.06 76.36 PHAEOCHROMOCYTOMA CRISIS | 1 0.01 76.37 PHARYNGEAL DISORDER | 2 0.02 76.39 PHARYNGEAL ERYTHEMA | 1 0.01 76.40 PHARYNGEAL HYPOAESTHESIA | 1 0.01 76.41 PHARYNGEAL OEDEMA | 6 0.06 76.47 PHARYNGITIS | 3 0.03 76.50 PHARYNGITIS STREPTOCOCCAL | 2 0.02 76.52 PHARYNGOTONSILLITIS | 1 0.01 76.53 PHOTODERMATOSIS | 1 0.01 76.54 PHOTOPHOBIA | 2 0.02 76.56 PHYSICAL ASSAULT | 1 0.01 76.57 PHYSICAL DISABILITY | 3 0.03 76.60 PIGMENTATION DISORDER | 1 0.01 76.61 PITUITARY TUMOUR | 1 0.01 76.62 PITUITARY TUMOUR BENIGN | 1 0.01 76.63 PITUITARY TUMOUR REMOVAL | 1 0.01 76.64 PLACENTA PRAEVIA | 1 0.01 76.65 PLACENTAL HYPERTROPHY | 1 0.01 76.66 PLANTAR FASCIITIS | 2 0.02 76.68 PLATELET COUNT ABNORMAL | 1 0.01 76.69 PLATELET COUNT DECREASED | 18 0.18 76.87 PLATELET COUNT INCREASED | 3 0.03 76.90 PLEURAL DISORDER | 1 0.01 76.91 PLEURAL EFFUSION | 19 0.19 77.10 PLEURISY | 3 0.03 77.13 PLEUROPERICARDITIS | 2 0.02 77.15 PNEUMOCOCCAL SEPSIS | 1 0.01 77.16 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 77.20 PNEUMONIA | 61 0.61 77.81 PNEUMONIA ASPIRATION | 4 0.04 77.85 PNEUMONIA BACTERIAL | 1 0.01 77.86 PNEUMONIA FUNGAL | 1 0.01 77.87 PNEUMONIA HERPES VIRAL | 1 0.01 77.88 PNEUMONIA INFLUENZAL | 1 0.01 77.89 PNEUMONIA VIRAL | 1 0.01 77.90 PNEUMONITIS | 6 0.06 77.96 PNEUMOTHORAX | 5 0.05 78.01 PO2 DECREASED | 1 0.01 78.02 POISONING | 3 0.03 78.05 POLLAKIURIA | 6 0.06 78.11 POLYARTHRITIS | 2 0.02 78.13 POLYCHROMASIA | 1 0.01 78.14 POLYP | 2 0.02 78.16 POLYP COLORECTAL | 1 0.01 78.17 POLYURIA | 2 0.02 78.19 POOR QUALITY DRUG ADMINISTERED | 1 0.01 78.20 POOR QUALITY SLEEP | 2 0.02 78.22 POOR VENOUS ACCESS | 13 0.13 78.35 PORTAL VEIN THROMBOSIS | 1 0.01 78.36 POST HERPETIC NEURALGIA | 1 0.01 78.37 POST PROCEDURAL COMPLICATION | 4 0.04 78.41 POST PROCEDURAL HAEMORRHAGE | 1 0.01 78.42 POST PROCEDURAL INFECTION | 1 0.01 78.43 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 78.44 POSTOPERATIVE THORACIC PROCEDURE COMP.. | 1 0.01 78.45 POSTOPERATIVE WOUND COMPLICATION | 1 0.01 78.46 POSTURE ABNORMAL | 1 0.01 78.47 POTENTIATING DRUG INTERACTION | 1 0.01 78.48 POUCHITIS | 1 0.01 78.49 PRE-ECLAMPSIA | 1 0.01 78.50 PRECANCEROUS SKIN LESION | 2 0.02 78.52 PREGNANCY | 22 0.22 78.74 PREGNANCY OF PARTNER | 2 0.02 78.76 PREGNANCY ON ORAL CONTRACEPTIVE | 2 0.02 78.78 PREGNANCY WITH CONTRACEPTIVE DEVICE | 1 0.01 78.79 PREMATURE LABOUR | 1 0.01 78.80 PREMATURE MENOPAUSE | 1 0.01 78.81 PREMATURE RUPTURE OF MEMBRANES | 2 0.02 78.83 PREMATURE SEPARATION OF PLACENTA | 1 0.01 78.84 PRESYNCOPE | 4 0.04 78.88 PRIMARY HYPOGONADISM | 1 0.01 78.89 PRIMARY SEQUESTRUM | 1 0.01 78.90 PROCALCITONIN INCREASED | 1 0.01 78.91 PROCEDURAL COMPLICATION | 1 0.01 78.92 PROCEDURAL PAIN | 3 0.03 78.95 PROCTALGIA | 2 0.02 78.97 PRODUCT ADHESION ISSUE | 2 0.02 78.99 PRODUCT COMMINGLING | 1 0.01 79.00 PRODUCT COMPOUNDING QUALITY ISSUE | 1 0.01 79.01 PRODUCT CONTAMINATION MICROBIAL | 3 0.03 79.04 PRODUCT LOT NUMBER ISSUE | 1 0.01 79.05 PRODUCT ODOUR ABNORMAL | 1 0.01 79.06 PRODUCT PACKAGING ISSUE | 2 0.02 79.08 PRODUCT QUALITY ISSUE | 38 0.38 79.46 PRODUCT SUBSTITUTION ISSUE | 2 0.02 79.48 PRODUCT TASTE ABNORMAL | 1 0.01 79.49 PRODUCTIVE COUGH | 5 0.05 79.54 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 2 0.02 79.56 PROGRESSIVE MULTIPLE SCLEROSIS | 2 0.02 79.58 PROPOFOL INFUSION SYNDROME | 1 0.01 79.59 PROSTATE CANCER | 4 0.04 79.63 PROSTATE CANCER METASTATIC | 1 0.01 79.64 PROSTATIC OBSTRUCTION | 1 0.01 79.65 PROSTATIC SPECIFIC ANTIGEN INCREASED | 5 0.05 79.70 PROSTHESIS IMPLANTATION | 1 0.01 79.71 PROTEIN TOTAL DECREASED | 2 0.02 79.73 PROTEIN URINE PRESENT | 1 0.01 79.74 PROTEINURIA | 3 0.03 79.77 PROTHROMBIN LEVEL DECREASED | 1 0.01 79.78 PROTHROMBIN TIME PROLONGED | 3 0.03 79.81 PRURIGO | 1 0.01 79.82 PRURITUS | 30 0.30 80.12 PRURITUS GENERALISED | 6 0.06 80.18 PSEUDARTHROSIS | 1 0.01 80.19 PSEUDOMONAL SEPSIS | 1 0.01 80.20 PSEUDOMONAS INFECTION | 4 0.04 80.24 PSEUDOPARALYSIS | 1 0.01 80.25 PSORIASIS | 6 0.06 80.31 PSYCHIATRIC DECOMPENSATION | 1 0.01 80.32 PSYCHIATRIC SYMPTOM | 1 0.01 80.33 PSYCHOMOTOR HYPERACTIVITY | 6 0.06 80.39 PSYCHOTIC DISORDER | 6 0.06 80.45 PSYCHOTIC DISORDER DUE TO A GENERAL M.. | 2 0.02 80.47 PUBIS FRACTURE | 2 0.02 80.49 PULMONARY ARTERIAL HYPERTENSION | 1 0.01 80.50 PULMONARY CONGESTION | 4 0.04 80.54 PULMONARY EMBOLISM | 16 0.16 80.70 PULMONARY FIBROSIS | 5 0.05 80.75 PULMONARY GRANULOMA | 1 0.01 80.76 PULMONARY HAEMORRHAGE | 1 0.01 80.77 PULMONARY HILAR ENLARGEMENT | 1 0.01 80.78 PULMONARY HYPERTENSION | 2 0.02 80.80 PULMONARY HYPOPLASIA | 1 0.01 80.81 PULMONARY INFARCTION | 1 0.01 80.82 PULMONARY OEDEMA | 11 0.11 80.93 PULMONARY SARCOIDOSIS | 1 0.01 80.94 PULMONARY THROMBOSIS | 2 0.02 80.96 PULMONARY TUBERCULOSIS | 1 0.01 80.97 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 80.98 PULPITIS DENTAL | 1 0.01 80.99 PUPILLARY LIGHT REFLEX TESTS ABNORMAL | 1 0.01 81.00 PUPILS UNEQUAL | 1 0.01 81.01 PURPURA | 1 0.01 81.02 PURULENCE | 1 0.01 81.03 PURULENT DISCHARGE | 4 0.04 81.07 PYELONEPHRITIS | 3 0.03 81.10 PYREXIA | 92 0.92 82.02 QRS AXIS ABNORMAL | 1 0.01 82.03 QUADRIPARESIS | 1 0.01 82.04 QUALITY OF LIFE DECREASED | 1 0.01 82.05 RADIATION SKIN INJURY | 1 0.01 82.06 RADICULAR SYNDROME | 1 0.01 82.07 RADICULOPATHY | 3 0.03 82.10 RADIOTHERAPY | 2 0.02 82.12 RADIUS FRACTURE | 2 0.02 82.14 RALES | 1 0.01 82.15 RASH | 41 0.41 82.56 RASH ERYTHEMATOUS | 2 0.02 82.58 RASH GENERALISED | 6 0.06 82.64 RASH MACULAR | 3 0.03 82.67 RASH MACULO-PAPULAR | 6 0.06 82.73 RASH PAPULAR | 6 0.06 82.79 RASH PRURITIC | 6 0.06 82.85 RASH PUSTULAR | 1 0.01 82.86 RASH VESICULAR | 2 0.02 82.88 RAYNAUD'S PHENOMENON | 2 0.02 82.90 REACTION TO COLOURING | 1 0.01 82.91 REACTION TO DRUG EXCIPIENTS | 1 0.01 82.92 REBOUND EFFECT | 1 0.01 82.93 RECTAL CANCER | 1 0.01 82.94 RECTAL HAEMORRHAGE | 5 0.05 82.99 RECTAL PERFORATION | 2 0.02 83.01 RECTAL PROLAPSE | 1 0.01 83.02 RECTAL ULCER | 1 0.01 83.03 RECTOCELE | 1 0.01 83.04 RECURRENT CANCER | 1 0.01 83.05 RED BLOOD CELL COUNT DECREASED | 3 0.03 83.08 RED BLOOD CELL SEDIMENTATION RATE INC.. | 4 0.04 83.12 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 83.13 REFLUX OESOPHAGITIS | 1 0.01 83.14 REGURGITATION | 1 0.01 83.15 RENAL ARTERY STENOSIS | 1 0.01 83.16 RENAL ATROPHY | 1 0.01 83.17 RENAL CELL CARCINOMA | 4 0.04 83.21 RENAL COLIC | 1 0.01 83.22 RENAL CYST | 2 0.02 83.24 RENAL DISORDER | 14 0.14 83.38 RENAL FAILURE | 37 0.37 83.75 RENAL FAILURE ACUTE | 31 0.31 84.06 RENAL FAILURE CHRONIC | 5 0.05 84.11 RENAL FUNCTION TEST ABNORMAL | 1 0.01 84.12 RENAL HAEMORRHAGE | 1 0.01 84.13 RENAL IMPAIRMENT | 15 0.15 84.28 RENAL MASS | 1 0.01 84.29 RENAL NEOPLASM | 1 0.01 84.30 RENAL PAIN | 1 0.01 84.31 RENAL TUBULAR DISORDER | 1 0.01 84.32 RENAL TUBULAR NECROSIS | 1 0.01 84.33 RESPIRATORY ARREST | 12 0.12 84.45 RESPIRATORY DEPRESSION | 1 0.01 84.46 RESPIRATORY DISORDER | 7 0.07 84.53 RESPIRATORY DISTRESS | 10 0.10 84.63 RESPIRATORY FAILURE | 21 0.21 84.84 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2 0.02 84.86 RESPIRATORY TRACT CONGESTION | 2 0.02 84.88 RESPIRATORY TRACT INFECTION | 6 0.06 84.94 RESPIRATORY TRACT INFECTION FUNGAL | 1 0.01 84.95 RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 84.96 RESTLESS LEGS SYNDROME | 1 0.01 84.97 RESTLESSNESS | 6 0.06 85.03 RESUSCITATION | 2 0.02 85.05 RETCHING | 1 0.01 85.06 RETINAL DISORDER | 1 0.01 85.07 RETINAL EXUDATES | 1 0.01 85.08 RETINAL HAEMORRHAGE | 1 0.01 85.09 RETINAL INJURY | 1 0.01 85.10 RETINAL PIGMENT EPITHELIAL TEAR | 1 0.01 85.11 RETINITIS | 1 0.01 85.12 RETINOPATHY | 1 0.01 85.13 RETINOPATHY HYPERTENSIVE | 1 0.01 85.14 RETROPERITONEAL ABSCESS | 1 0.01 85.15 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 3 0.03 85.18 RHABDOMYOLYSIS | 8 0.08 85.26 RHEUMATOID ARTHRITIS | 10 0.10 85.36 RHEUMATOID VASCULITIS | 1 0.01 85.37 RHINITIS PERENNIAL | 1 0.01 85.38 RHINORRHOEA | 6 0.06 85.44 RIB FRACTURE | 6 0.06 85.50 RIGHT ATRIAL DILATATION | 1 0.01 85.51 ROAD TRAFFIC ACCIDENT | 12 0.12 85.63 ROTATOR CUFF REPAIR | 1 0.01 85.64 ROTATOR CUFF SYNDROME | 3 0.03 85.67 SACROILIITIS | 1 0.01 85.68 SALIVARY DUCT OBSTRUCTION | 1 0.01 85.69 SALIVARY HYPERSECRETION | 1 0.01 85.70 SALPINGO-OOPHORECTOMY BILATERAL | 1 0.01 85.71 SARCOIDOSIS | 1 0.01 85.72 SARCOMA | 1 0.01 85.73 SARCOMA UTERUS | 1 0.01 85.74 SCAR | 4 0.04 85.78 SCAR EXCISION | 1 0.01 85.79 SCHIZOAFFECTIVE DISORDER | 1 0.01 85.80 SCHIZOPHRENIA | 2 0.02 85.82 SCIATICA | 4 0.04 85.86 SCLERODERMA | 1 0.01 85.87 SCOLIOSIS | 4 0.04 85.91 SCRATCH | 2 0.02 85.93 SCREAMING | 2 0.02 85.95 SCROTAL SWELLING | 1 0.01 85.96 SEBORRHOEIC KERATOSIS | 2 0.02 85.98 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 2 0.02 86.00 SECRETION DISCHARGE | 1 0.01 86.01 SEDATION | 1 0.01 86.02 SELF ESTEEM DECREASED | 1 0.01 86.03 SELF INJURIOUS BEHAVIOUR | 2 0.02 86.05 SELF-MEDICATION | 1 0.01 86.06 SEMINOMA | 1 0.01 86.07 SENSATION OF HEAVINESS | 5 0.05 86.12 SENSATION OF PRESSURE | 1 0.01 86.13 SENSITIVITY OF TEETH | 1 0.01 86.14 SENSORY DISTURBANCE | 7 0.07 86.21 SENSORY LOSS | 1 0.01 86.22 SEPSIS | 29 0.29 86.51 SEPTIC SHOCK | 10 0.10 86.61 SEQUESTRECTOMY | 4 0.04 86.65 SEROSITIS | 2 0.02 86.67 SEROTONIN SYNDROME | 1 0.01 86.68 SERRATIA INFECTION | 1 0.01 86.69 SERUM FERRITIN INCREASED | 1 0.01 86.70 SERUM SICKNESS | 2 0.02 86.72 SEXUAL DYSFUNCTION | 2 0.02 86.74 SHOCK | 7 0.07 86.81 SHOCK HAEMORRHAGIC | 3 0.03 86.84 SHUNT INFECTION | 1 0.01 86.85 SIALOADENITIS | 1 0.01 86.86 SICKLE CELL ANAEMIA WITH CRISIS | 2 0.02 86.88 SIGMOIDITIS | 1 0.01 86.89 SINGLE FUNCTIONAL KIDNEY | 1 0.01 86.90 SINUS BRADYCARDIA | 1 0.01 86.91 SINUS CONGESTION | 1 0.01 86.92 SINUS DISORDER | 7 0.07 86.99 SINUS HEADACHE | 3 0.03 87.02 SINUS POLYP | 1 0.01 87.03 SINUS TACHYCARDIA | 3 0.03 87.06 SINUSITIS | 18 0.18 87.24 SKELETAL INJURY | 4 0.04 87.28 SKIN ATROPHY | 1 0.01 87.29 SKIN BURNING SENSATION | 3 0.03 87.32 SKIN CANCER | 3 0.03 87.35 SKIN CHAPPED | 1 0.01 87.36 SKIN DISCOLOURATION | 6 0.06 87.42 SKIN DISORDER | 1 0.01 87.43 SKIN EROSION | 1 0.01 87.44 SKIN EXFOLIATION | 4 0.04 87.48 SKIN INFECTION | 2 0.02 87.50 SKIN INJURY | 1 0.01 87.51 SKIN IRRITATION | 2 0.02 87.53 SKIN LACERATION | 3 0.03 87.56 SKIN LESION | 9 0.09 87.65 SKIN NEOPLASM EXCISION | 1 0.01 87.66 SKIN PAPILLOMA | 2 0.02 87.68 SKIN PLAQUE | 1 0.01 87.69 SKIN REACTION | 2 0.02 87.71 SKIN STRIAE | 1 0.01 87.72 SKIN ULCER | 8 0.08 87.80 SKIN WARM | 1 0.01 87.81 SLEEP APNOEA SYNDROME | 5 0.05 87.86 SLEEP DISORDER | 9 0.09 87.95 SLEEP TERROR | 1 0.01 87.96 SLUGGISHNESS | 2 0.02 87.98 SMALL INTESTINAL OBSTRUCTION | 5 0.05 88.03 SMALL INTESTINAL PERFORATION | 1 0.01 88.04 SMEAR CERVIX ABNORMAL | 1 0.01 88.05 SOCIAL AVOIDANT BEHAVIOUR | 2 0.02 88.07 SOMNAMBULISM | 2 0.02 88.09 SOMNOLENCE | 21 0.21 88.30 SOPOR | 6 0.06 88.36 SPEECH DISORDER | 11 0.11 88.47 SPERM COUNT DECREASED | 1 0.01 88.48 SPERMATOZOA PROGRESSIVE MOTILITY DECR.. | 1 0.01 88.49 SPHINCTER OF ODDI DYSFUNCTION | 1 0.01 88.50 SPINAL COLUMN STENOSIS | 5 0.05 88.55 SPINAL COMPRESSION FRACTURE | 2 0.02 88.57 SPINAL CORD COMPRESSION | 1 0.01 88.58 SPINAL CORD DISORDER | 1 0.01 88.59 SPINAL CORD INFECTION | 1 0.01 88.60 SPINAL CORD OEDEMA | 1 0.01 88.61 SPINAL CORPECTOMY | 1 0.01 88.62 SPINAL DISORDER | 3 0.03 88.65 SPINAL FRACTURE | 4 0.04 88.69 SPINAL FUSION SURGERY | 1 0.01 88.70 SPINAL LAMINECTOMY | 1 0.01 88.71 SPINAL OPERATION | 1 0.01 88.72 SPINAL OSTEOARTHRITIS | 6 0.06 88.78 SPLENECTOMY | 1 0.01 88.79 SPLENIC ARTERY ANEURYSM | 1 0.01 88.80 SPLENIC HAEMATOMA | 1 0.01 88.81 SPLENIC HAEMORRHAGE | 1 0.01 88.82 SPLENIC RUPTURE | 1 0.01 88.83 SPLENOMEGALY | 2 0.02 88.85 SPONDYLOLISTHESIS | 2 0.02 88.87 SQUAMOUS CELL CARCINOMA | 6 0.06 88.93 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 88.94 STAPHYLOCOCCAL BACTERAEMIA | 3 0.03 88.97 STAPHYLOCOCCAL INFECTION | 15 0.15 89.12 STAPHYLOCOCCAL SEPSIS | 2 0.02 89.14 STAPHYLOCOCCAL SKIN INFECTION | 1 0.01 89.15 STEATORRHOEA | 1 0.01 89.16 STEM CELL TRANSPLANT | 2 0.02 89.18 STENT PLACEMENT | 2 0.02 89.20 STEREOTYPY | 1 0.01 89.21 STEVENS-JOHNSON SYNDROME | 11 0.11 89.32 STILLBIRTH | 1 0.01 89.33 STOMATITIS | 8 0.08 89.41 STOMATITIS NECROTISING | 1 0.01 89.42 STRABISMUS | 1 0.01 89.43 STREPTOCOCCAL BACTERAEMIA | 1 0.01 89.44 STREPTOCOCCAL IMPETIGO | 1 0.01 89.45 STRESS | 22 0.22 89.67 STRESS CARDIOMYOPATHY | 1 0.01 89.68 STRESS FRACTURE | 3 0.03 89.71 STRESS URINARY INCONTINENCE | 1 0.01 89.72 SUBCUTANEOUS NODULE | 1 0.01 89.73 SUBDURAL HAEMATOMA | 4 0.04 89.77 SUBILEUS | 1 0.01 89.78 SUBSTANCE ABUSE | 1 0.01 89.79 SUDDEN CARDIAC DEATH | 2 0.02 89.81 SUDDEN DEATH | 4 0.04 89.85 SUICIDAL BEHAVIOUR | 2 0.02 89.87 SUICIDAL IDEATION | 18 0.18 90.05 SUICIDE ATTEMPT | 14 0.14 90.19 SUPPRESSED LACTATION | 1 0.01 90.20 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 90.21 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 90.24 SURGERY | 14 0.14 90.38 SUTURE RUPTURE | 1 0.01 90.39 SWELLING | 12 0.12 90.51 SWELLING FACE | 16 0.16 90.67 SWOLLEN TONGUE | 7 0.07 90.74 SYNCOPE | 26 0.26 91.00 SYNOVIAL CYST | 1 0.01 91.01 SYNOVITIS | 2 0.02 91.03 SYPHILIS | 1 0.01 91.04 SYRINGE ISSUE | 1 0.01 91.05 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 91.06 SYSTEMIC LUPUS ERYTHEMATOSUS | 4 0.04 91.10 SYSTEMIC MYCOSIS | 1 0.01 91.11 TACHYARRHYTHMIA | 3 0.03 91.14 TACHYCARDIA | 22 0.22 91.36 TACHYCARDIA PAROXYSMAL | 1 0.01 91.37 TACHYPNOEA | 2 0.02 91.39 TARDIVE DYSKINESIA | 1 0.01 91.40 TEARFULNESS | 1 0.01 91.41 TEMPERATURE INTOLERANCE | 1 0.01 91.42 TEMPORAL ARTERITIS | 1 0.01 91.43 TEMPORAL LOBE EPILEPSY | 1 0.01 91.44 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 91.45 TENDON PAIN | 1 0.01 91.46 TENDON RUPTURE | 5 0.05 91.51 TENDONITIS | 5 0.05 91.56 TENSION | 1 0.01 91.57 TENSION HEADACHE | 1 0.01 91.58 TERATOMA | 1 0.01 91.59 TESTICULAR ATROPHY | 1 0.01 91.60 THERAPEUTIC AGENT TOXICITY | 3 0.03 91.63 THERAPEUTIC RESPONSE DECREASED | 8 0.08 91.71 THERAPEUTIC RESPONSE UNEXPECTED | 2 0.02 91.73 THERMAL BURN | 1 0.01 91.74 THINKING ABNORMAL | 1 0.01 91.75 THIRST | 1 0.01 91.76 THORACIC VERTEBRAL FRACTURE | 2 0.02 91.78 THROAT CANCER | 1 0.01 91.79 THROAT IRRITATION | 3 0.03 91.82 THROAT TIGHTNESS | 3 0.03 91.85 THROMBOCYTOPENIA | 26 0.26 92.11 THROMBOCYTOSIS | 1 0.01 92.12 THROMBOPHLEBITIS | 1 0.01 92.13 THROMBOSIS | 16 0.16 92.29 THROMBOSIS IN DEVICE | 1 0.01 92.30 THROMBOTIC MICROANGIOPATHY | 2 0.02 92.32 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 92.33 THYROID CANCER | 2 0.02 92.35 THYROID DISORDER | 5 0.05 92.40 THYROID FUNCTION TEST ABNORMAL | 2 0.02 92.42 THYROID NEOPLASM | 2 0.02 92.44 THYROIDECTOMY | 1 0.01 92.45 THYROXINE FREE ABNORMAL | 1 0.01 92.46 TIBIA FRACTURE | 2 0.02 92.48 TIC | 3 0.03 92.51 TINNITUS | 5 0.05 92.56 TONGUE BLISTERING | 1 0.01 92.57 TONGUE DISORDER | 1 0.01 92.58 TONGUE ERUPTION | 1 0.01 92.59 TONGUE OEDEMA | 2 0.02 92.61 TONGUE ULCERATION | 3 0.03 92.64 TONIC CONVULSION | 1 0.01 92.65 TONSILLITIS | 2 0.02 92.67 TOOTH ABSCESS | 2 0.02 92.69 TOOTH DISORDER | 15 0.15 92.84 TOOTH EXTRACTION | 12 0.12 92.96 TOOTH FRACTURE | 9 0.09 93.05 TOOTH INFECTION | 3 0.03 93.08 TOOTH INJURY | 1 0.01 93.09 TOOTH LOSS | 3 0.03 93.12 TOOTHACHE | 6 0.06 93.18 TORSADE DE POINTES | 1 0.01 93.19 TOXIC ANTERIOR SEGMENT SYNDROME | 1 0.01 93.20 TOXIC EPIDERMAL NECROLYSIS | 6 0.06 93.26 TOXIC SKIN ERUPTION | 7 0.07 93.33 TRACHEOSTOMY | 1 0.01 93.34 TRACHEOSTOMY MALFUNCTION | 1 0.01 93.35 TRANCE | 1 0.01 93.36 TRANSAMINASES INCREASED | 3 0.03 93.39 TRANSFUSION | 1 0.01 93.40 TRANSIENT ISCHAEMIC ATTACK | 10 0.10 93.50 TRANSIENT TACHYPNOEA OF THE NEWBORN | 1 0.01 93.51 TRANSMISSION OF AN INFECTIOUS AGENT V.. | 32 0.32 93.83 TRANSPLANT REJECTION | 4 0.04 93.87 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 93.88 TRAUMATIC LIVER INJURY | 1 0.01 93.89 TRAUMATIC LUMBAR PUNCTURE | 1 0.01 93.90 TREATMENT FAILURE | 1 0.01 93.91 TREATMENT NONCOMPLIANCE | 6 0.06 93.97 TREMOR | 33 0.33 94.30 TRICUSPID VALVE INCOMPETENCE | 1 0.01 94.31 TRICUSPID VALVE REPLACEMENT | 1 0.01 94.32 TRIGEMINAL NEURALGIA | 2 0.02 94.34 TRISMUS | 3 0.03 94.37 TUBERCULOSIS | 6 0.06 94.43 TUBULOINTERSTITIAL NEPHRITIS | 1 0.01 94.44 TUMOUR FLARE | 2 0.02 94.46 TUMOUR LYSIS SYNDROME | 2 0.02 94.48 TYPE 2 DIABETES MELLITUS | 2 0.02 94.50 TYPHOID FEVER | 1 0.01 94.51 ULCER | 4 0.04 94.55 ULCER HAEMORRHAGE | 3 0.03 94.58 ULCERATIVE KERATITIS | 2 0.02 94.60 UMBILICAL HERNIA | 2 0.02 94.62 UNDERDOSE | 1 0.01 94.63 UNEVALUABLE EVENT | 5 0.05 94.68 UNINTENDED PREGNANCY | 6 0.06 94.74 UNRESPONSIVE TO STIMULI | 3 0.03 94.77 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 94.78 UPPER LIMB FRACTURE | 5 0.05 94.83 UPPER RESPIRATORY TRACT CONGESTION | 1 0.01 94.84 UPPER RESPIRATORY TRACT INFECTION | 13 0.13 94.97 UPPER RESPIRATORY TRACT INFLAMMATION | 2 0.02 94.99 URETERAL STENT INSERTION | 1 0.01 95.00 URETERIC STENOSIS | 1 0.01 95.01 URETHRAL CARUNCLE | 1 0.01 95.02 URINARY INCONTINENCE | 10 0.10 95.12 URINARY RETENTION | 5 0.05 95.17 URINARY TRACT DISORDER | 2 0.02 95.19 URINARY TRACT INFECTION | 35 0.35 95.54 URINARY TRACT INFECTION BACTERIAL | 1 0.01 95.55 URINARY TRACT OPERATION | 1 0.01 95.56 URINE ABNORMALITY | 1 0.01 95.57 URINE COLOUR ABNORMAL | 1 0.01 95.58 URINE OUTPUT DECREASED | 2 0.02 95.60 URINE OUTPUT INCREASED | 1 0.01 95.61 UROSEPSIS | 2 0.02 95.63 URTICARIA | 17 0.17 95.80 UTERINE DILATION AND CURETTAGE | 1 0.01 95.81 UTERINE INFECTION | 1 0.01 95.82 UTERINE LEIOMYOMA | 3 0.03 95.85 UTERINE PERFORATION | 1 0.01 95.86 UTERINE PROLAPSE | 1 0.01 95.87 UTERINE STENOSIS | 1 0.01 95.88 VACCINATION COMPLICATION | 1 0.01 95.89 VAGINAL CYST | 1 0.01 95.90 VAGINAL HAEMORRHAGE | 14 0.14 96.04 VAGINAL INFECTION | 5 0.05 96.09 VAGINAL MUCOSAL BLISTERING | 1 0.01 96.10 VAGINAL POLYP | 1 0.01 96.11 VAGINITIS BACTERIAL | 1 0.01 96.12 VARICELLA | 1 0.01 96.13 VARICES OESOPHAGEAL | 1 0.01 96.14 VARICOSE VEIN | 1 0.01 96.15 VASCULAR CALCIFICATION | 1 0.01 96.16 VASCULAR GRAFT | 2 0.02 96.18 VASCULAR GRAFT OCCLUSION | 1 0.01 96.19 VASCULAR OCCLUSION | 1 0.01 96.20 VASCULAR PROCEDURE COMPLICATION | 1 0.01 96.21 VASCULAR PSEUDOANEURYSM | 1 0.01 96.22 VASCULAR PURPURA | 1 0.01 96.23 VASCULITIS | 3 0.03 96.26 VASCULITIS CEREBRAL | 1 0.01 96.27 VASODILATATION | 1 0.01 96.28 VASODILATION PROCEDURE | 1 0.01 96.29 VEIN DISCOLOURATION | 1 0.01 96.30 VENA CAVA THROMBOSIS | 1 0.01 96.31 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.32 VENOUS INSUFFICIENCY | 1 0.01 96.33 VENOUS PRESSURE JUGULAR INCREASED | 1 0.01 96.34 VENTRICULAR ARRHYTHMIA | 1 0.01 96.35 VENTRICULAR EXTRASYSTOLES | 2 0.02 96.37 VENTRICULAR FIBRILLATION | 4 0.04 96.41 VENTRICULAR HYPERTROPHY | 1 0.01 96.42 VENTRICULAR HYPOKINESIA | 2 0.02 96.44 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.45 VENTRICULAR TACHYCARDIA | 5 0.05 96.50 VERBAL ABUSE | 1 0.01 96.51 VERTEBROPLASTY | 2 0.02 96.53 VERTIGO | 16 0.16 96.69 VERTIGO POSITIONAL | 1 0.01 96.70 VESTIBULAR DISORDER | 1 0.01 96.71 VICTIM OF CRIME | 1 0.01 96.72 VICTIM OF HOMICIDE | 1 0.01 96.73 VIRAL INFECTION | 4 0.04 96.77 VIROLOGIC FAILURE | 1 0.01 96.78 VISION BLURRED | 24 0.24 97.02 VISUAL ACUITY REDUCED | 10 0.10 97.12 VISUAL ACUITY REDUCED TRANSIENTLY | 1 0.01 97.13 VISUAL FIELD DEFECT | 1 0.01 97.14 VISUAL IMPAIRMENT | 21 0.21 97.35 VITAMIN B12 DEFICIENCY | 1 0.01 97.36 VITAMIN D DECREASED | 3 0.03 97.39 VITAMIN K DECREASED | 1 0.01 97.40 VITRECTOMY | 1 0.01 97.41 VITREOUS FLOATERS | 1 0.01 97.42 VOCAL CORD DISORDER | 2 0.02 97.44 VOCAL CORD PARESIS | 1 0.01 97.45 VOMITING | 88 0.88 98.33 VOMITING PROJECTILE | 1 0.01 98.34 VULVAL CELLULITIS | 1 0.01 98.35 VULVOVAGINAL DRYNESS | 1 0.01 98.36 VULVOVAGINAL MYCOTIC INFECTION | 1 0.01 98.37 WAIST CIRCUMFERENCE INCREASED | 2 0.02 98.39 WALKING AID USER | 1 0.01 98.40 WEIGHT DECREASED | 53 0.53 98.93 WEIGHT FLUCTUATION | 1 0.01 98.94 WEIGHT INCREASED | 45 0.45 99.39 WHEELCHAIR USER | 1 0.01 99.40 WHEEZING | 10 0.10 99.50 WHITE BLOOD CELL COUNT DECREASED | 10 0.10 99.60 WHITE BLOOD CELL COUNT INCREASED | 5 0.05 99.65 WHITE BLOOD CELL DISORDER | 1 0.01 99.66 WITHDRAWAL SYNDROME | 9 0.09 99.75 WOUND | 3 0.03 99.78 WOUND ABSCESS | 2 0.02 99.80 WOUND DEHISCENCE | 2 0.02 99.82 WOUND INFECTION | 1 0.01 99.83 WOUND TREATMENT | 1 0.01 99.84 WRIST FRACTURE | 3 0.03 99.87 WRONG DRUG ADMINISTERED | 1 0.01 99.88 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 11 0.11 99.99 YELLOW SKIN | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015